{"content":"<li class=\"n-box-item date-title\" data-end=\"1521777599\" data-start=\"1521691200\" data-txt=\"Monday, December 23, 2019\">Thursday, March 22, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3341172\" data-ts=\"1521761922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341172-nike-acquires-zodiac-post-earnings-gains-rise-to-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nike acquires Zodiac; post-earnings gains rise to 6%</a></h4><ul>   <li>Nike (NYSE:<a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a>) has <a href=\"https://seekingalpha.com/pr/17110328-nike-inc-acquires-data-analytics-leader-zodiac\" target=\"_blank\">acquired Zodiac Inc.</a>, a consumer data analytics firm, a deal that \"demonstrates our commitment to further accelerating Nike&rsquo;s digital transformation and enhancing our consumer data and analytics capabilities to help us serve consumers globally,&rdquo; says Chief Digital Officer Adam Sussman.</li>    <li>&ldquo;We&rsquo;re adding world-class data-science talent and best-in-class tools to power 1:1 relationships with consumers through digital and physical consumer experiences.&rdquo;</li>    <li>After-hours gains following the company's <a href=\"https://seekingalpha.com/news/3341132-nike-plus-2_5-percent-revenues-inventories-grow-q3\" target=\"_blank\">solid Q3 earnings</a> have grown to <font color='green'>+6%</font> alongside a conference call where CEO Mark Parker pointed to a \"significant\" reversal of trend in North America.</li>    <li>That comes after a year where the company dealt with inventory buildup and store closures at home.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3341172\" data-linked=\"Nike acquires Zodiac; post-earnings gains rise to 6%\" data-tweet=\"$NKE - Nike acquires Zodiac; post-earnings gains rise to 6% https://seekingalpha.com/news/3341172-nike-acquires-zodiac-post-earnings-gains-rise-to-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3341172-nike-acquires-zodiac-post-earnings-gains-rise-to-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341160\" data-ts=\"1521754524\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGH\" target=\"_blank\">SGH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341160-after-hours-gainers-losers-3-22-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (3/22/2018)</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/SGH' title='SMART Global Holdings'>SGH</a> <font color='green'>+11.2%</font>. <a href='https://seekingalpha.com/symbol/HOME' title='At Home Group'>HOME</a> <font color='green'>+8.1%</font>. <a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a> <font color='green'>+7.1%</font>. <a href='https://seekingalpha.com/symbol/GSUM' title='Gridsum Holding'>GSUM</a> <font color='green'>+3.9%</font>. <a href='https://seekingalpha.com/symbol/CTAS' title='Cintas Corporation'>CTAS</a> <font color='green'>+3.5%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/PGNX' title='Progenics Pharmaceuticals Inc.'>PGNX</a> <font color='red'>-18.2%</font>. <a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics'>LPTX</a> <font color='red'>-8.1%</font>. <a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics'>PTI</a> <font color='red'>-2.6%</font>. <a href='https://seekingalpha.com/symbol/KBH' title='KB Home'>KBH</a> <font color='red'>-2.0%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3341160\" data-linked=\"After Hours Gainers / Losers (3/22/2018)\" data-tweet=\"$SGH $SGH $HOME - After Hours Gainers / Losers (3/22/2018) https://seekingalpha.com/news/3341160-after-hours-gainers-losers-3-22-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3341160-after-hours-gainers-losers-3-22-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341157\" data-ts=\"1521753542\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTAS\" target=\"_blank\">CTAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341157-cintasplus-3_5-on-q3-beat-solid-profit-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cintas +3.5% on Q3 beat, solid profit guidance</a></h4><ul>   <li>Cintas (NASDAQ:<a href='https://seekingalpha.com/symbol/CTAS' title='Cintas Corporation'>CTAS</a>) has <font color='green'>gained 3.5%</font> in postmarket trading, making up some of the day's losses, after posting <a href=\"https://seekingalpha.com/news/3341127-cintas-beats-0_10-beats-revenue\" target=\"_blank\">Q3 earnings</a> where revenues climbed nearly 30% boosted by a key acquisition, and profit guidance for the current quarter topped expectations.</li>    <li>Revenues grew 7.8% on an organic basis, excluding forex effects and the acquisition of G&amp;K Services. Organic revenue grew 6.5% in the company's core Uniform rental and facility services business, and rose 10% in First Aid and Safety Services.</li>    <li>Operating income rose 4.2% to $200M, affected by a one-time cash payment of about $40M to employees following tax legislation.</li>    <li>Net income from continuing operations rose 153% to $296M.</li>    <li>Revenue breakout: Uniform rental and facility services, $1.285B (up 30%); Other, $304.6M (up 14%).</li>    <li>The company says tax reform makes comparability difficult in forecasting full fiscal year results; but for Q4 it sees revenues of $1.625B-$1.645B (vs. consensus for $1.629B) and EPS from continuing operations of $1.64-$1.69 (above consensus for $1.46), excluding G&amp;K transaction/integration expenses.</li>    <li><a href=\"https://seekingalpha.com/pr/17110202-cintas-corporation-announces-fiscal-2018-third-quarter-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3341157\" data-linked=\"Cintas +3.5% on Q3 beat, solid profit guidance\" data-tweet=\"$CTAS - Cintas +3.5% on Q3 beat, solid profit guidance https://seekingalpha.com/news/3341157-cintasplus-3_5-on-q3-beat-solid-profit-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3341157-cintasplus-3_5-on-q3-beat-solid-profit-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341137\" data-ts=\"1521751489\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KBH\" target=\"_blank\">KBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341137-kb-homes-up-2_5-after-hours-amid-revenue-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KB Homes up 2.5% after hours amid revenue miss</a></h4><ul><li>FQ1 pretax income of $46M or $0.53 per share vs. $21.5M and $0.22 a year ago.</li><li>Deliveries flat at 2,223 homes.</li><li>Average selling price up 7% to $389.8K.</li><li>Net order value up 8% to $1.17B, up 8% in units to 2,784.</li><li>Backlog order value up 10% to $1.97B, up 4% in units at 4,972.</li><li>Excluding inventory-related charges, housing gross profit margin up 160 basis points to 16.7%; operating income margin up 200 bps to 5.6%.</li><li><a href=\"http://www.kbhome.com/\" target=\"_blank\">Conference call at 5 p.m. ET</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3341116-kb-home-beats-0_12-misses-revenue\" target=\"_blank\">KB Home beats by $0.12, misses on revenue</a> (March 22)</li><li><a href='https://seekingalpha.com/symbol/KBH' title='KB Home'>KBH</a> <font color='green'>+2.5%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3341137\" data-linked=\"KB Homes up 2.5% after hours amid revenue miss\" data-tweet=\"$KBH - KB Homes up 2.5% after hours amid revenue miss https://seekingalpha.com/news/3341137-kb-homes-up-2_5-after-hours-amid-revenue-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3341137-kb-homes-up-2_5-after-hours-amid-revenue-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341139\" data-ts=\"1521751130\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDGS\" target=\"_blank\">MDGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341139-medigus-reports-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medigus reports Q4 results</a></h4><ul><li>Medigus (NASDAQ:<a href='https://seekingalpha.com/symbol/MDGS' title='Medigus Ltd'>MDGS</a>): Q4 Operating loss&nbsp;of $1.27M</li><li>Revenue of $0.15M (+200.0% Y/Y)</li><li>Shares <font color='green'>+20.59%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17110173-medigus-ltd-announces-fourth-quarter-fiscal-year-2017-financial-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3341139\" data-linked=\"Medigus reports Q4 results\" data-tweet=\"$MDGS - Medigus reports Q4 results https://seekingalpha.com/news/3341139-medigus-reports-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3341139-medigus-reports-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341132\" data-ts=\"1521750509\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341132-nikeplus-2_5-revenues-inventories-grow-in-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nike +2.5% as revenues, inventories grow in Q3</a></h4><ul>   <li>After a down day, Nike (NYSE:<a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a>) is <font color='green'>up 2.5%</font> after hours following <a href=\"https://seekingalpha.com/news/3341124-nike-eps-0_68\" target=\"_blank\">fiscal Q3 earnings</a> where it took a loss due to a large tax expense it took after new legislation, but saw revenues grow with worldwide gains.</li>    <li>Overall revenues rose 6.6%; Revenues for Nike brand rose 4% in constant currency to $8.5B, driven by Greater China, EMEA and APLA, including double-digit growth in Nike Direct and growth in Sportswear and Nike Basketball.</li>    <li>As for Converse, revenues fell 8% in constant currency to $483M, dragged by North American declines that more than offset gains in international and digital.</li>    <li>A loss of $0.57/share saw an impact of $1.25/share due to a $2B tax expense it took after new legislation passed. The company noted an effective tax rate of 179.5%.</li>    <li>At Feb. 28, inventories were $5.4B (up 9% Y/Y due to stronger global demand and changes in exchange rates).</li>    <li>Cash, equivalents and short-term investments were $4.8B, down $1.4% Y/Y on buybacks, dividends and infrastructure investments.</li>    <li><a href=\"http://investors.nike.com\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17110206-nike-inc-reports-fiscal-2018-third-quarter-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3341132\" data-linked=\"Nike +2.5% as revenues, inventories grow in Q3\" data-tweet=\"$NKE - Nike +2.5% as revenues, inventories grow in Q3 https://seekingalpha.com/news/3341132-nikeplus-2_5-revenues-inventories-grow-in-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3341132-nikeplus-2_5-revenues-inventories-grow-in-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341129\" data-ts=\"1521750375\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341129-micronminus-1-after-q2-beats-upside-guidance-dram-guidance-up-nand-down\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron -1% after Q2 beats, upside guidance; DRAM guidance up, NAND down</a></h4><ul><li>        Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>) shares&nbsp;<font color='red'>drop 1%</font>&nbsp;aftermarket on Q2 results that beat EPS and revenue estimates.</li><li>               Upside Q3 guidance has revenue from $7.2B to $7.6B (consensus: $7.29B) and EPS from $2.76 to $2.90 (consensus: $2.66). Gross margin expected from 57% to 60%, operating expenses from $700M to $750M, and operating income from $3.6B to $3.8B.&nbsp;</li><li>               DRAM guidance: CY18 industry supply bit growth expected at about 20%, which is consistent with the last earnings report&rsquo;s guidance. But Micron ups its own expectations from slightly below that figure to in-line performance.&nbsp;</li><li>               NAND guidance: CY18 industry supply bit growth expected at about 45% (down 5 percentage points from last quarter) and Micron expects its growth &ldquo;somewhat above&rdquo; the industry, which is the same forecast for a lower industry figure.&nbsp;</li><li>               Key metrics: Gross margin, 58.4%; operating cash flow, $4.35B; operating expenses, $703M ; cash and equivalents, $8.04B; total debt, $9.3B.&nbsp;</li><li>               Earnings call is scheduled for 4:30 PM ET with a webcast available <a href=\"http://investors.micron.com/events.cfm\" target=\"_blank\">here</a>.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17110147-micron-technology-inc-reports-results-second-quarter-fiscal-2018\" target=\"_blank\">Press release</a> / <a href=\"http://files.shareholder.com/downloads/ABEA-45YXOQ/6108371695x0x975012/0D34223A-4050-4793-BA70-8C0319C7ADB4/Micron_FQ2-2018_Earnings_Call_Presentation_Slides.pdf\" target=\"_blank\">Presentation slides</a>&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3341104-micron-technology-beats-0_08-beats-revenue\" target=\"_blank\">Micron Technology beats by $0.08, beats on revenue</a> (March 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3341129\" data-linked=\"Micron -1% after Q2 beats, upside guidance; DRAM guidance up, NAND down\" data-tweet=\"$MU - Micron -1% after Q2 beats, upside guidance; DRAM guidance up, NAND down https://seekingalpha.com/news/3341129-micronminus-1-after-q2-beats-upside-guidance-dram-guidance-up-nand-down?source=tweet\" data-url=\"https://seekingalpha.com/news/3341129-micronminus-1-after-q2-beats-upside-guidance-dram-guidance-up-nand-down\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>173&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341127\" data-ts=\"1521750095\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTAS\" target=\"_blank\">CTAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341127-cintas-beats-0_10-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cintas beats by $0.10, beats on revenue</a></h4><ul><li>Cintas (NASDAQ:<a href='https://seekingalpha.com/symbol/CTAS' title='Cintas Corporation'>CTAS</a>): Q3 EPS of $1.37 <font color='green'>beats by $0.10</font>.</li><li>Revenue of $1.59B (+27.2% Y/Y) <font color='green'>beats by $20M</font>.</li><li>Shares <font color='green'>+4.22%</font>.</li><li><a href='https://seekingalpha.com/pr/17110202-cintas-corporation-announces-fiscal-2018-third-quarter-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3341127\" data-linked=\"Cintas beats by $0.10, beats on revenue\" data-tweet=\"$CTAS - Cintas beats by $0.10, beats on revenue https://seekingalpha.com/news/3341127-cintas-beats-0_10-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3341127-cintas-beats-0_10-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341118\" data-ts=\"1521749677\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPTX\" target=\"_blank\">LPTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341118-leap-therapeutics-readies-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leap Therapeutics readies stock offering</a></h4><ul><li>Leap Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics'>LPTX</a>) <a href=\"https://seekingalpha.com/pr/17110171-leap-therapeutics-announces-proposed-public-offering-common-stock\" target=\"_blank\">initiates </a>a public offering of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3341118\" data-linked=\"Leap Therapeutics readies stock offering\" data-tweet=\"$LPTX - Leap Therapeutics readies stock offering https://seekingalpha.com/news/3341118-leap-therapeutics-readies-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3341118-leap-therapeutics-readies-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341109\" data-ts=\"1521749188\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTGM\" target=\"_blank\">HTGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341109-htg-molecular-beats-0_16-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HTG Molecular beats by $0.16, beats on revenue</a></h4><ul><li>HTG Molecular (NASDAQ:<a href='https://seekingalpha.com/symbol/HTGM' title='HTG Molecular Diagnostics'>HTGM</a>): Q4 EPS of -$0.15 <font color='green'>beats by $0.16</font>.</li><li>Revenue of $7.9M (+441.1% Y/Y) <font color='green'>beats by $0.92M</font>.</li><li>Shares <font color='green'>+2.04%</font>.</li><li><a href='https://seekingalpha.com/pr/17110153-htg-molecular-diagnostics-reports-fourth-quarter-full-year-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3341109\" data-linked=\"HTG Molecular beats by $0.16, beats on revenue\" data-tweet=\"$HTGM - HTG Molecular beats by $0.16, beats on revenue https://seekingalpha.com/news/3341109-htg-molecular-beats-0_16-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3341109-htg-molecular-beats-0_16-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341102\" data-ts=\"1521748693\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDX\" target=\"_blank\">FDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341102-fedex-falls-5-amid-fear-of-china-tariffs-on-company-global-economy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FedEx falls 5% amid fear of China tariffs on company, global economy</a></h4><ul><li>FedEx (<a href='https://seekingalpha.com/symbol/FDX' title='FedEx Corporation'>FDX</a> <font color='red'>-5%</font>) <a href=\"https://www.bloomberg.com/news/articles/2018-03-22/fedex-tumbles-on-fear-china-tariffs-will-batter-global-economy\" target=\"_blank\">falls the most in nearly six weeks</a> as investor fear the impact of Pres. Trump's tariffs on at least $50B in Chinese imports and heed the warning of CEO Fred Smith that the tariffs could threaten U.S. economic health.</li><li>&ldquo;It&rsquo;s definitely the tariffs on China impacting&rdquo; the shares, says Seaport Global analyst Kevin  Sterling. &ldquo;If global trade does  contract, they&rsquo;re going to feel it.&rdquo;</li><li>Asia accounts for ~10% of FDX&rsquo;s revenue vs. 5%-7% for UPS (<a href='https://seekingalpha.com/symbol/UPS' title='United Parcel Service, Inc.'>UPS</a> <font color='red'>-2.9%</font>), Baird analyst Benjamin Hartford estimates, adding that China would be the &ldquo;dominant component&rdquo; of the  Asian figures.</li><li>FDX's <a href=\"https://seekingalpha.com/news/3340552-fedex-plus-2_6-percent-revenue-boost-fuel-impact-drives-profit-gains\" target=\"_blank\">FQ3 results</a> also may be weighing on the  shares, says Bloomberg's Lee Klaskow, noting &ldquo;some concerns&rdquo; regarding FDX's Express airline unit, the company's largest.</li></ul><div class=\"tiny-share-widget\" data-id=\"3341102\" data-linked=\"FedEx falls 5% amid fear of China tariffs on company, global economy\" data-tweet=\"$FDX $FDX $UPS - FedEx falls 5% amid fear of China tariffs on company, global economy https://seekingalpha.com/news/3341102-fedex-falls-5-amid-fear-of-china-tariffs-on-company-global-economy?source=tweet\" data-url=\"https://seekingalpha.com/news/3341102-fedex-falls-5-amid-fear-of-china-tariffs-on-company-global-economy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341100\" data-ts=\"1521748359\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTL\" target=\"_blank\">CTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341100-centurylink-staffing-up-new-small-business-sales-center\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CenturyLink staffing up new small-business sales center</a></h4><ul>   <li>In an update on its push to set up a <a href=\"https://seekingalpha.com/news/3327570-centurylink-building-sales-center-focused-small-business\" target=\"_blank\">small-business sales center</a> in its hometown, CenturyLink (<a href=\"http://seekingalpha.com/symbol/CTL\" target=\"_blank\">CTL</a> <font color='red'>-3.2%</font>) says it's <a href=\"https://seekingalpha.com/pr/17110129-centurylinks-vernon-irvin-shares-update-small-business-center-hiring\" target=\"_blank\">partly staffed up</a> after a successful hiring event.</li>    <li>We couldn't be happier with the results of our job fair and hiring efforts thus far for the small business sales center,\" says CenturyLink's Vernon Irvin. \"The community has responded positively to helping us fill these positions, with more than 500 individuals participating in our job fair last month, and nearly 70 new employees in training now.</li>    <li>The company has planned to hire 150 workers in Monroe, La., to help expand the company's customer base among small businesses.</li>    <li>It plans to fill out the hiring by the end of the year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3341100\" data-linked=\"CenturyLink staffing up new small-business sales center\" data-tweet=\"$CTL - CenturyLink staffing up new small-business sales center https://seekingalpha.com/news/3341100-centurylink-staffing-up-new-small-business-sales-center?source=tweet\" data-url=\"https://seekingalpha.com/news/3341100-centurylink-staffing-up-new-small-business-sales-center\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341097\" data-ts=\"1521747590\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TCEHY\" target=\"_blank\">TCEHY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341097-chinese-internet-stocks-drop-tencent-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chinese internet stocks drop with Tencent news</a></h4><ul><li>        Chinese internet&ndash;related stocks continue to feel pressure from Tencent&rsquo;s (<a href='https://seekingalpha.com/symbol/TCEHY' title='Tencent Holding Ltd. ADR'>OTCPK:TCEHY</a> <font color='red'>-10%</font>) plans to focus on investments rather than short-term margins and Naspers&rsquo; $10.6B sale of Tencent shares.</li><li>               Peers moving on the news: Vipshop Holdings (<a href='https://seekingalpha.com/symbol/VIPS' title='Vipshop Holdings'>VIPS</a> <font color='red'>-9.7%</font>), Baozun (<a href='https://seekingalpha.com/symbol/BZUN' title='Baozun'>BZUN</a> <font color='red'>-10%</font>), SINA (<a href='https://seekingalpha.com/symbol/SINA' title='Sina Corporation'>SINA</a> <font color='red'>-6.6%</font>), YY (<a href='https://seekingalpha.com/symbol/YY' title='YY Inc.'>YY</a> <font color='red'>-5.9%</font>), Baidu (<a href='https://seekingalpha.com/symbol/BIDU' title='Baidu, Inc.'>BIDU</a> <font color='red'>-5.8%</font>), NetEase (<a href='https://seekingalpha.com/symbol/NTES' title='NetEase, Inc'>NTES</a> <font color='red'>-5.4%</font>), Autohome (<a href='https://seekingalpha.com/symbol/ATHM' title='Autohome Inc.'>ATHM</a> <font color='red'>-3.3%</font>), Alibaba (<a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a> <font color='red'>-5.3%</font>), Xunlei (<a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a> <font color='red'>-3.8%</font>), Ctrip.com (<a href='https://seekingalpha.com/symbol/CTRP' title='Ctrip.com International, Ltd.'>CTRP</a> <font color='red'>-2.6%</font>), Silicon Motion (<a href='https://seekingalpha.com/symbol/SIMO' title='Silicon Motion Technology Corporation'>SIMO</a> <font color='red'>-2.7%</font>), 58.com (<a href='https://seekingalpha.com/symbol/WUBA' title='58.com Inc.'>WUBA</a> <font color='red'>-3%</font>), JD.com (<a href='https://seekingalpha.com/symbol/JD' title='JD.com'>JD</a> <font color='red'>-2.7%</font>), Sohu.com (<a href='https://seekingalpha.com/symbol/SOHU' title='Sohu.com Inc.'>SOHU</a> <font color='red'>-3.8%</font>), and Momo (<a href='https://seekingalpha.com/symbol/MOMO' title='Momo'>MOMO</a> <font color='red'>-2.7%</font>).&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3340941-naspers-sells-10_6b-tencent-shares\" target=\"_blank\">Naspers sells $10.6B of Tencent shares</a> (March 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3341097\" data-linked=\"Chinese internet stocks drop with Tencent news\" data-tweet=\"$TCEHY $TCEHY $VIPS - Chinese internet stocks drop with Tencent news https://seekingalpha.com/news/3341097-chinese-internet-stocks-drop-tencent-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3341097-chinese-internet-stocks-drop-tencent-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>69&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341092\" data-ts=\"1521746910\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GES\" target=\"_blank\">GES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341092-guessplus-29-big-q4-overshadows-co-founders-misconduct-probe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guess +29% as big Q4 overshadows co-founder&#39;s misconduct probe</a></h4><ul>     <li>Guess? (<a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a> <font color='green'>+29.3%</font>) spikes to a new 52-week high amid its <a href=\"https://www.bloomberg.com/news/articles/2018-03-22/guess-jumps-as-faster-sales-overshadow-misconduct-investigation\" target=\"_blank\">best one-day gain in nearly 20 years</a> following the company's <a href=\"https://seekingalpha.com/news/3340847-guess-jumps-11-percent-q4-profits-top-high-estimates\" target=\"_blank\">strong Q4 results</a>, fueled by rapid growth in Europe and Asia and signs of recovery in the U.S.</li>     <li>Telsey Advisory Group <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Guess+%28GES%29+PT+Raised+to+%2418+at+Telsey%3B+Positive+Operating+Momentum+Continues/13972277.html\" target=\"_blank\">raises its price target</a> to $18 from $17, saying the overall operating momentum continues in a positive direction as profitability turned positive in the Americas through lower markdowns and cost savings on closed stores and rent reductions, while the European wholesale order book is on track for its third consecutive season of double digit growth, and operating margin expansion in Asia has been strong; however, comps in the Americas likely will continue to decline this year as the business looks to continue to shrink, though to a more profitable level.</li>     <li>But Telsey still rates the stock a Hold as &ldquo;headline risk remains&rdquo; due to the investigation into sexual misconduct claims against co-founder, chairman and chief creative officer Paul Marciano; the company sidestepped questions about the allegations during today's earnings conference call.</li></ul><div class=\"tiny-share-widget\" data-id=\"3341092\" data-linked=\"Guess +29% as big Q4 overshadows co-founder&#39;s misconduct probe\" data-tweet=\"$GES - Guess +29% as big Q4 overshadows co-founder&#39;s misconduct probe https://seekingalpha.com/news/3341092-guessplus-29-big-q4-overshadows-co-founders-misconduct-probe?source=tweet\" data-url=\"https://seekingalpha.com/news/3341092-guessplus-29-big-q4-overshadows-co-founders-misconduct-probe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341091\" data-ts=\"1521746789\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITRI\" target=\"_blank\">ITRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341091-macquarie-initiates-itron\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macquarie initiates Itron</a></h4><ul><li>        Macquarie <a href=\"https://www.streetinsider.com/New+Coverage/Macquarie+Starts+Itron+%28ITRI%29+at+Neutral+Citing+Balanced+RiskReturn+Profile/13974743.html\" target=\"_blank\">initiates</a> Itron (NASDAQ:<a href='https://seekingalpha.com/symbol/ITRI' title='Itron, Inc.'>ITRI</a>) with a Neutral rating.</li><li>                  Latest analyst <a href=\"https://markets.ft.com/data/equities/tearsheet/forecasts?s=ITRI:NSQ\" target=\"_blank\">recommendations</a>: 5 Buy, 3 Outperform, 4 Hold, and 1 Underperform.    </li><li>               Median price target: $84.&nbsp;</li><li>               Itron shares are&nbsp;<font color='red'>down 1.3%</font>&nbsp;to $72.02.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3341091\" data-linked=\"Macquarie initiates Itron\" data-tweet=\"$ITRI - Macquarie initiates Itron https://seekingalpha.com/news/3341091-macquarie-initiates-itron?source=tweet\" data-url=\"https://seekingalpha.com/news/3341091-macquarie-initiates-itron\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341076\" data-ts=\"1521745909\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNJN\" target=\"_blank\">FNJN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341076-finjan-sues-carbon-black-for-patent-infringement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finjan sues Carbon Black for patent infringement</a></h4><ul><li>        Finjan (NASDAQ:<a href='https://seekingalpha.com/symbol/FNJN' title='Finjan Holdings, Inc.'>FNJN</a>) <a href=\"https://seekingalpha.com/pr/17110026-finjan-files-patent-infringement-complaint-carbon-black-inc\" target=\"_blank\">files a patent infringement lawsuit</a> against Carbon Black.</li><li>               Finjan accuses Carbon Black of violating at least four patents and seeks a jury trial, infringement judgment, injunctions, and past damages.&nbsp;</li><li>           Finjan shares are&nbsp;<font color='red'>down 1.3%</font>&nbsp;to $3.10.&nbsp;                    </li></ul><div class=\"tiny-share-widget\" data-id=\"3341076\" data-linked=\"Finjan sues Carbon Black for patent infringement\" data-tweet=\"$FNJN - Finjan sues Carbon Black for patent infringement https://seekingalpha.com/news/3341076-finjan-sues-carbon-black-for-patent-infringement?source=tweet\" data-url=\"https://seekingalpha.com/news/3341076-finjan-sues-carbon-black-for-patent-infringement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341072\" data-ts=\"1521745159\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OBE\" target=\"_blank\">OBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341072-obsidian-energy-slams-investor-over-time-consuming-distracting-proxy-fight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Obsidian Energy slams investor over &#39;time-consuming, distracting proxy fight&#39;</a></h4><ul>     <li>Obsidian Energy (<a href='https://seekingalpha.com/symbol/OBE' title='Obsidian Energy Ltd.'>OBE</a> <font color='red'>-4.2%</font>) and activist investor FrontFour Capital have been <a href=\"http://business.financialpost.com/commodities/energy/time-consuming-and-distracting-proxy-fight-obsidian-energy-trades-barbs-with-activist-investor\" target=\"_blank\">trading insults</a> this week over the appointment of new directors, which the company says would give the hedge fund control over its board.</li><li>FrontFour had launched the fight on Tuesday by <a href=\"https://seekingalpha.com/pr/17107619-frontfour-releases-letter-obsidian-shareholders\" target=\"_blank\">nominating four directors</a> to OBE&rsquo;s nine-person board, with the company saying the moves are a <a href=\"https://seekingalpha.com/pr/17107845-obsidian-energy-frontfour-risking-companys-progress\" target=\"_blank\">distraction</a> and that it has cooperated with the hedge fund by already adding retired investment banker Gordon Ritchie to the board.</li><li>FrontFour did suggest Ritchie as a director but OBE already  was considering him for a board seat, says FrontFour's Stephen Loukas, who is being nominated by his firm as a board member; FrontFour owns 6.2% of OBE&rsquo;s shares.</li><li>The hedge fund wants OBE to sell off its older natural gas assets  and operations in two Alberta oil and gas formations to focus solely  on its properties in the Cardium light oil formation.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3341072\" data-linked=\"Obsidian Energy slams investor over &#39;time-consuming, distracting proxy fight&#39;\" data-tweet=\"$OBE - Obsidian Energy slams investor over &#39;time-consuming, distracting proxy fight&#39; https://seekingalpha.com/news/3341072-obsidian-energy-slams-investor-over-time-consuming-distracting-proxy-fight?source=tweet\" data-url=\"https://seekingalpha.com/news/3341072-obsidian-energy-slams-investor-over-time-consuming-distracting-proxy-fight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>100&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341037\" data-ts=\"1521744406\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENSV\" target=\"_blank\">ENSV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341037-enservco-down-12-on-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ENSERVCO down 12% on Q4 results</a></h4><ul><li>ENSERVCO (<a href='https://seekingalpha.com/symbol/ENSV' title='Enservco Corp.'>ENSV</a> <font color='red'>-12.9%</font>) recorded a revenue growth of 112 % Y/Y to $14.1M. Segment revenue: Well enhancement services +158% Y/Y to $12.9M, water transfer +79% Y/Y to $0.27M and water hauling +10% Y/Y to $1M.</li><li>Under well enhancement segment: hot oiling +37% Y/Y to $3M, frac water heating +267% Y/Y to $7.6M and acidizing +168% Y/Y to $1.6M.</li><li>Q4 overall operating income&nbsp;<font color='green'>recovered by 5440 bps</font>&nbsp;to 4.60%. Well enhancement segment&rsquo;s operating margin&nbsp;<font color='green'>improved by 1138 bps</font>&nbsp;to 30.23%.</li><li>Adjusted EBITDA margin<font color='green'> up 3538 bps</font>&nbsp;to 17.23%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3340925-enservco-reports-q4-results\" target=\"_blank\">Enservco reports Q4 results</a> (March 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3341037\" data-linked=\"ENSERVCO down 12% on Q4 results\" data-tweet=\"$ENSV - ENSERVCO down 12% on Q4 results https://seekingalpha.com/news/3341037-enservco-down-12-on-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3341037-enservco-down-12-on-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341071\" data-ts=\"1521744318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSNN\" target=\"_blank\">FSNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341071-technology-top-5-gainers-losers-of-2-45-pm-03-22-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2:45 PM (03/22/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FSNN' title='Fusion Connect, Inc.'>FSNN</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='green'>+10%</font>.IFON <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/PDVW' title='pdvWireless, Inc.'>PDVW</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SITO' title='SITO Mobile, Ltd.'>SITO</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/SCON' title='Superconductor Technologies Inc.'>SCON</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/RESN' title='Resonant'>RESN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/AYI' title='Acuity Brands, Inc. &#40;Holding Company&#41;'>AYI</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3341071\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2:45 PM (03/22/2018)\" data-tweet=\"$FSNN $FSNN $LFIN - Technology - Top 5 Gainers / Losers as of 2:45 PM (03/22/2018) https://seekingalpha.com/news/3341071-technology-top-5-gainers-losers-of-2-45-pm-03-22-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3341071-technology-top-5-gainers-losers-of-2-45-pm-03-22-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341049\" data-ts=\"1521744293\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWMC\" target=\"_blank\">TWMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341049-trans-world-entertainment-down-5-on-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trans World Entertainment down 5% on Q4 results</a></h4><ul><li>Trans World Entertainment (<a href='https://seekingalpha.com/symbol/TWMC' title='Trans World Entertainment Corp.'>TWMC</a> <font color='red'>-5.7%</font>) Q4 revenue was down 1% Y/Y to $145.4M. Segment revenues: fye -19.6% Y/Y to $92.4M and etailz +31.3% Y/Y to $53.01M.</li><li>Overall operating margin<font color='red'> fell by 2839 bps</font>&nbsp;to -22.16%. This quarter the company included a non-cash charge of $29.1M, impairment against certain long-lived assets in the fye segment.</li><li>Segment operating margin fye&nbsp;<font color='red'>declined&nbsp;</font>by 4172 bps&nbsp;to -34.15% and etailz&nbsp;<font color='red'>declined by 344 bps</font>&nbsp;to -1.27%.</li><li>Adjusted EBITDA margin&nbsp;<font color='red'>declined by 737 bps</font>&nbsp;to -0.23%.</li><li>SG&amp;A expenses margin<font color='green'> improved by 206 bps&nbsp;</font>to 29.1%.</li><li>Inventory was at $109.6M FY2017, which included $23.4M from etailz.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3340933-trans-world-reports-q4-results\" target=\"_blank\">Trans World reports Q4 results</a> (March 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3341049\" data-linked=\"Trans World Entertainment down 5% on Q4 results\" data-tweet=\"$TWMC - Trans World Entertainment down 5% on Q4 results https://seekingalpha.com/news/3341049-trans-world-entertainment-down-5-on-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3341049-trans-world-entertainment-down-5-on-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341070\" data-ts=\"1521744047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341070-apple-will-fix-bug-let-siri-read-hidden-notifications\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple will fix bug that let Siri read hidden notifications</a></h4><ul><li>Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) will <a href=\"https://www.macrumors.com/2018/03/22/apple-to-fix-siri-reading-hidden-notifications/\" target=\"_blank\">fix a bug</a> that allowed Siri to read hidden lock screen notifications to anyone asking.</li><li>Company statement to MacRumors: \u201cWe are aware of the issue and it will be addressed in an upcoming software update.\u201d</li><li>The bug kept iMessages and SMS texts private but allowed Siri to read Facebook Messenger, Slack, email apps, and more.</li><li>Apple shares are<font color=\"green\">up 0.08%</font>to $171.41.</li></ul><div class=\"tiny-share-widget\" data-id=\"3341070\" data-linked=\"Apple will fix bug that let Siri read hidden notifications\" data-tweet=\"$AAPL $WORK - Apple will fix bug that let Siri read hidden notifications https://seekingalpha.com/news/3341070-apple-will-fix-bug-let-siri-read-hidden-notifications?source=tweet\" data-url=\"https://seekingalpha.com/news/3341070-apple-will-fix-bug-let-siri-read-hidden-notifications\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341069\" data-ts=\"1521744040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPM\" target=\"_blank\">WPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341069-wheaton-precious-metalsplus-2-2017-production-beats-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wheaton Precious Metals +2% as 2017 production beats guidance</a></h4><ul>     <li>Wheaton Precious Metals (<a href='https://seekingalpha.com/symbol/WPM' title='Wheaton Precious Metals Corp'>WPM</a> <font color='green'>+2%</font>) is higher after reporting better than expected <a href=\"https://seekingalpha.com/news/3340858-wheaton-precious-metals-beats-0_03-beats-revenue\" target=\"_blank\">Q4 earnings</a> and revenues, and declaring a <a href=\"https://seekingalpha.com/news/3340855-wheaton-precious-metals-declares-0_09-dividend\" target=\"_blank\">Q4 dividend</a> that was 29% higher than in the year-ago quarter.</li>     <li>Q4 production came in at 7.2M oz. of silver, down 5% Y/Y primarily due to lower production from the San Dimas mine resulting from various operational issues, and nearly 96.5K oz. of gold, down 13.6% Y/Y because the company's share of gold production at the 777 mine was cut from 100% to 50%.</li>     <li>WPM says it generated $165M of operating cash flow during Q4, resulting in more than $535M for the year.</li>     <li>For the full year, WPM says attributable silver production totaled 28.6M oz. and gold output was 355K oz., exceeding company production guidance of 28M oz. of silver and 340K oz. of gold.; silver sales volume fell 13% Y/Y to 24,6K oz. while gold sales volume hit a record 337.2K oz.</li>     <li>WPM expects FY 2018 attributable production of 22.5M oz. of silver and 355K&nbsp;oz. of gold, and forecasts average annual  attributable production over the next five years including 2018 of 25M oz. of silver and 370K&nbsp;oz. of  gold.</li></ul><div class=\"tiny-share-widget\" data-id=\"3341069\" data-linked=\"Wheaton Precious Metals +2% as 2017 production beats guidance\" data-tweet=\"$WPM - Wheaton Precious Metals +2% as 2017 production beats guidance https://seekingalpha.com/news/3341069-wheaton-precious-metalsplus-2-2017-production-beats-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3341069-wheaton-precious-metalsplus-2-2017-production-beats-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341068\" data-ts=\"1521742470\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LNG\" target=\"_blank\">LNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341068-cheniere-says-sabine-pass-tanks-shutdown-order-unwarranted\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cheniere says Sabine Pass tanks&#39; shutdown order unwarranted</a></h4><ul>     <li>Cheniere Energy (<a href='https://seekingalpha.com/symbol/LNG' title='Cheniere Energy, Inc'>LNG</a> <font color='red'>-2.9%</font>) says federal pipeline regulators <a href=\"https://www.eenews.net/stories/1060077135\" target=\"_blank\">overstated the danger to the public</a> posed by leaks from tanks at its Sabine Pass natural gas export site in Louisiana.</li><li>Officials with the Pipeline and Hazardous Materials Safety  Administration cited potential hazards to \"life, property and the  environment\" when it ordered fixes last month to two tanks at the facility, but Cheniere's attorney told a hearing yesterday that the leaks posed no public threat even in a  worst-case scenario.</li><li>LNG requested the hearing when it challenged PHMSA's Feb. 8 order requiring the shutdown and an investigation that revealed personnel at the facility have been grappling with a series of  storage tank issues dating back to the site's 2008 opening.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3341068\" data-linked=\"Cheniere says Sabine Pass tanks&#39; shutdown order unwarranted\" data-tweet=\"$LNG - Cheniere says Sabine Pass tanks&#39; shutdown order unwarranted https://seekingalpha.com/news/3341068-cheniere-says-sabine-pass-tanks-shutdown-order-unwarranted?source=tweet\" data-url=\"https://seekingalpha.com/news/3341068-cheniere-says-sabine-pass-tanks-shutdown-order-unwarranted\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341067\" data-ts=\"1521741903\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MELI\" target=\"_blank\">MELI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341067-mercadolibreminus-1_6-following-underweight-restart-morgan-stanley\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MercadoLibre -1.6% following Underweight restart by Morgan Stanley</a></h4><ul>   <li>MercadoLibre (NASDAQ:<a href='https://seekingalpha.com/symbol/MELI' title='MercadoLibre, Inc.'>MELI</a>) is <font color='red'>1.6% lower</font> after Morgan Stanley reinstated an Underweight rating.</li>    <li>The company's headed for a long period of lower profits due to a strategy that values faster growth through marketing and promotions like free shipping, the firm says. That's a net negative for cash flow as well, and single-digit margins will be a reality for at least the next three years. (h/t Bloomberg)</li>    <li>As for an Amazon.com move into Brazil, the threat there is still small, the analysts say, with a bigger threat coming in Mexico.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3341067\" data-linked=\"MercadoLibre -1.6% following Underweight restart by Morgan Stanley\" data-tweet=\"$MELI - MercadoLibre -1.6% following Underweight restart by Morgan Stanley https://seekingalpha.com/news/3341067-mercadolibreminus-1_6-following-underweight-restart-morgan-stanley?source=tweet\" data-url=\"https://seekingalpha.com/news/3341067-mercadolibreminus-1_6-following-underweight-restart-morgan-stanley\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341066\" data-ts=\"1521741609\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMTX\" target=\"_blank\">AMTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341066-energy-materials-top-gainers-losers-of-2-00-pm-03-22-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm (03/22/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/USEG' title='U.S. Energy Corp.'>USEG</a> <font color='green'>+10%</font>.<a href='https://seekingalpha.com/symbol/TDW' title='Tidewater, Inc.'>TDW</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/FGP' title='Ferrellgas Partners L.P'>FGP</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CENX' title='Century Aluminum Company'>CENX</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ENSV' title='Enservco Corp.'>ENSV</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3341066\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm (03/22/2018)\" data-tweet=\"$AMTX $AMTX $USEG - Energy/Materials - Top Gainers / Losers as of 2:00 pm (03/22/2018) https://seekingalpha.com/news/3341066-energy-materials-top-gainers-losers-of-2-00-pm-03-22-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3341066-energy-materials-top-gainers-losers-of-2-00-pm-03-22-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341171\" data-ts=\"1521740851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMEX\" target=\"_blank\">OMEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341171-odyssey-marine-doubles-on-favorable-mexican-court-ruling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Odyssey Marine more than doubles on favorable Mexican court ruling</a></h4><ul>     <li>Odyssey Marine Exploration (<a href='https://seekingalpha.com/symbol/OMEX' title='Odyssey Marine Exploration, Inc.'>OMEX</a> <font color='green'>+117.9%</font>) explodes to a three-year high after disclosing that a Mexican federal court <a href=\"http://ir.odysseymarine.com/static-files/3df6ffc2-122f-4161-9e6c-c7714de20e71\" target=\"_blank\">ruled unanimously in favor</a> of its Exploraciones Oce&aacute;nicas subsidiary nullifying the denial of an  environmental permit application for the extraction of phosphate sand  from its Don Diego project.</li>     <li>OMEX holds a 53.8% ownership interest in ExO.</li></ul><div class=\"tiny-share-widget\" data-id=\"3341171\" data-linked=\"Odyssey Marine more than doubles on favorable Mexican court ruling\" data-tweet=\"$OMEX - Odyssey Marine more than doubles on favorable Mexican court ruling https://seekingalpha.com/news/3341171-odyssey-marine-doubles-on-favorable-mexican-court-ruling?source=tweet\" data-url=\"https://seekingalpha.com/news/3341171-odyssey-marine-doubles-on-favorable-mexican-court-ruling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341063\" data-ts=\"1521740387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341063-steel-stocks-slide-u-s-tariff-waivers-pile-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steel stocks slide as U.S. tariff waivers pile up</a></h4><ul>     <li><a href=\"https://www.bloomberg.com/news/articles/2018-03-22/steel-stocks-tumble-as-u-s-tariff-waivers-water-down-benefits\" target=\"_blank\">Steel stocks tumble</a> as the Trump tariffs on steel and aluminum imports into the U.S. don't look so tough after all: <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='red'>-6.9%</font>, <a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='red'>-5.1%</font>, <a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color='red'>-3.4%</font>, <a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='red'>-5.4%</font>, <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='red'>-3.8%</font>, <a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a> <font color='red'>-3.8%</font>, <a href='https://seekingalpha.com/symbol/RS' title='Reliance Steel & Aluminum Co.'>RS</a> <font color='red'>-4.1%</font>, <a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a> <font color='red'>-4.2%</font>, <a href='https://seekingalpha.com/symbol/CENX' title='Century Aluminum Company'>CENX</a> <font color='red'>-13.1%</font>, <a href='https://seekingalpha.com/symbol/CSTM' title='Constellium Holdco B.V.'>CSTM</a> <font color='red'>-4.8%</font>, <a href='https://seekingalpha.com/symbol/KALU' title='Kaiser Aluminum Corporation'>KALU</a> <font color='red'>-1%</font>, <a href='https://seekingalpha.com/symbol/TECK' title='Teck Resources Limited'>TECK</a> <font color='red'>-2.8%</font>.</li>     <li>U.S. Trade Representative Robert Lighthizer told a Senate hearing today that the European Union, Australia, South Korea, Argentina and Brazil would get a temporary exemption from the tariffs, although Japan would not get an exemption.</li>     <li>The Trump administration already had exempted Canada and Mexico as long as they agreed to an updated NAFTA deal.</li><li>ETF: <a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a>, <a href='https://seekingalpha.com/symbol/XME' title='SPDR S&P Metals and Mining ETF'>XME</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3341063\" data-linked=\"Steel stocks slide as U.S. tariff waivers pile up\" data-tweet=\"$X $X $AKS - Steel stocks slide as U.S. tariff waivers pile up https://seekingalpha.com/news/3341063-steel-stocks-slide-u-s-tariff-waivers-pile-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3341063-steel-stocks-slide-u-s-tariff-waivers-pile-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>112&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341062\" data-ts=\"1521739766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZN\" target=\"_blank\">AZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341062-astrazeneca-crosses-finish-line-in-europe-hyperkalemia-drug-zsminus-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AstraZeneca crosses the finish line in Europe with hyperkalemia drug ZS-9</a></h4><ul><li>The European Commission <a href=\"https://www.astrazeneca.com/media-centre/press-releases/2018/lokelma-approved-in-the-eu-for-the-treatment-of-adults-with-hyperkalaemia-22032018.html\" target=\"_blank\">approves </a>AstraZeneca's (<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a> <font color='green'>+0.2%</font>) Lokelma (sodium zirconium cyclosilicate), formerly known as ZS-9, for the treatment of adults with hyperkalemia (elevated blood potassium).</li><li>The approval is a long-awaited breakthrough from the company's $2.7B takeout of ZS Pharma in 2015.</li><li>U.S. approval is the next big opportunity. The FDA issued a second CRL a year ago. The third marketing application has yet to be submitted.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3246449-astrazeneca-closing-marketing-approvals-hyperkalemia-med-zsminus-9\" target=\"_blank\">AstraZeneca closing in on marketing approvals for hyperkalemia med ZS-9</a> (Feb. 24, 2017)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3251962-bad-news-astrazenecas-potassium-drug\" target=\"_blank\">Bad news again for AstraZeneca's potassium drug</a> (March 17, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3341062\" data-linked=\"AstraZeneca crosses the finish line in Europe with hyperkalemia drug ZS-9\" data-tweet=\"$AZN - AstraZeneca crosses the finish line in Europe with hyperkalemia drug ZS-9 https://seekingalpha.com/news/3341062-astrazeneca-crosses-finish-line-in-europe-hyperkalemia-drug-zsminus-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3341062-astrazeneca-crosses-finish-line-in-europe-hyperkalemia-drug-zsminus-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341059\" data-ts=\"1521738793\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITRI\" target=\"_blank\">ITRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341059-itron-signs-three-year-contract-for-water-meters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Itron signs three-year contract for water meters</a></h4><ul><li>        Itron (NASDAQ:<a href='https://seekingalpha.com/symbol/ITRI' title='Itron, Inc.'>ITRI</a>) and Jordan Water Company (Miyahuna) <a href=\"https://seekingalpha.com/pr/17109520-itron-expands-work-jordan-address-non-revenue-water\" target=\"_blank\">sign a three-year contract</a> for water meters and analysis. Financial terms not disclosed.</li><li>               The contract with Al Darb comes after a bid to buy 76,000 ultrasonic meters and software.&nbsp;</li><li>               The utility will use an Itron system and static metering technology plus its analytic services to reduce water losses. &nbsp;&nbsp;&nbsp;</li><li>               Miyahuna provides water services to 670,000 customers in Jordan, a region that faces water scarcity challenges.&nbsp;</li><li>               Itron shares are&nbsp;<font color='red'>down 0.9%</font>&nbsp;to $72.35.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3341059\" data-linked=\"Itron signs three-year contract for water meters\" data-tweet=\"$ITRI - Itron signs three-year contract for water meters https://seekingalpha.com/news/3341059-itron-signs-three-year-contract-for-water-meters?source=tweet\" data-url=\"https://seekingalpha.com/news/3341059-itron-signs-three-year-contract-for-water-meters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341057\" data-ts=\"1521738201\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUAN\" target=\"_blank\">NUAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341057-ncr-coo-heading-to-nuance-communications\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NCR COO heading to Nuance Communications</a></h4><ul><li>Nuance Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/NUAN' title='Nuance Communications, Inc.'>NUAN</a>) <a href=\"https://seekingalpha.com/pr/17109623-nuance-appoints-mark-benjamin-chief-executive-officer\" target=\"_blank\">appoints</a> Mark Benjamin as the new CEO effective April 23.</li><li>Benjamin succeeds the retiring Paul Ricci and currently serves as COO of NCR Corporation (NYSE:<a href='https://seekingalpha.com/symbol/NCR' title='NCR Corporation'>NCR</a>).</li><li>Nuance shares are&nbsp;<font color='red'>down 0.9%</font>&nbsp;to $16.70.</li><li>NCR shares are&nbsp;<font color='red'>down 2.7%</font>&nbsp;to $32.35.</li><li>Correction: Piece updated to correct Benjamin's NCR role to COO, not CEO.</li></ul><div class=\"tiny-share-widget\" data-id=\"3341057\" data-linked=\"NCR COO heading to Nuance Communications\" data-tweet=\"$NUAN $NUAN $NCR - NCR COO heading to Nuance Communications https://seekingalpha.com/news/3341057-ncr-coo-heading-to-nuance-communications?source=tweet\" data-url=\"https://seekingalpha.com/news/3341057-ncr-coo-heading-to-nuance-communications\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341052\" data-ts=\"1521738043\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSEC\" target=\"_blank\">PSEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341052-financials-top-5-gainers-losers-of-1-00-pm-03-22-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM (03/22/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PSEC' title='Prospect Capital Corporation'>PSEC</a> <font color='green'>+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3341052\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM (03/22/2018)\" data-tweet=\"$PSEC - Financials - Top 5 Gainers / Losers as of 1:00 PM (03/22/2018) https://seekingalpha.com/news/3341052-financials-top-5-gainers-losers-of-1-00-pm-03-22-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3341052-financials-top-5-gainers-losers-of-1-00-pm-03-22-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341053\" data-ts=\"1521737809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341053-argus-raises-nvidia-target-to-14-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Argus raises its Nvidia target to 14% upside</a></h4><ul><li>        Argus <a href=\"https://www.streetinsider.com/Analyst+Comments/NVIDIA+%28NVDA%29+PT+Raised+to+%24280+at+Argus%3B+Reiterates+Buy/13973203.html\" target=\"_blank\">maintains</a> a Buy rating and raises its Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) price target from $250 to $280, a 14% upside to yesterday&rsquo;s close.&nbsp;</li><li>               Firm says that gaming remains Nvidia&rsquo;s largest end market and source of profit growth.&nbsp;</li><li>               Nvidia shares are&nbsp;<font color='red'>down 1%</font>&nbsp;to $246.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3341053\" data-linked=\"Argus raises its Nvidia target to 14% upside\" data-tweet=\"$NVDA - Argus raises its Nvidia target to 14% upside https://seekingalpha.com/news/3341053-argus-raises-nvidia-target-to-14-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3341053-argus-raises-nvidia-target-to-14-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341051\" data-ts=\"1521737106\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMEX\" target=\"_blank\">OMEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341051-midday-gainers-losers-03-22-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (03/22/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/OMEX' title='Odyssey Marine Exploration, Inc.'>OMEX</a> <font color='green'>+153%</font>. <a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='green'>+38%</font>. <a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/LE' title='Lands&#39; End, Inc.'>LE</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/TTNP' title='Titan Pharmaceuticals, Inc.'>TTNP</a> <font color='green'>+19%</font>.  <a href='https://seekingalpha.com/symbol/EARS' title='Auris Medical Holding'>EARS</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/SNGX' title='Soligenix, Inc.'>SNGX</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/FSNN' title='Fusion Connect, Inc.'>FSNN</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/INNT' title='Innovate Biopharmaceuticals, Inc.'>INNT</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/IFMK' title='iFresh Inc.'>IFMK</a> <font color='green'>+16%</font>.</li><li><a href='https://seekingalpha.com/symbol/CALI' title='China Auto Logistics Inc.'>OTC:CALI</a>&nbsp;<font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/SCON' title='Superconductor Technologies Inc.'>SCON</a>&nbsp;<font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a>&nbsp;<font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CENX' title='Century Aluminum Company'>CENX</a>&nbsp;<font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/ENSV' title='Enservco Corp.'>ENSV</a>&nbsp;<font color='red'>-12%</font>.  <a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, LTD.'>GIII</a>&nbsp;<font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/MLHR' title='Herman Miller, Inc.'>MLHR</a>&nbsp;<font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/SITO' title='SITO Mobile, Ltd.'>SITO</a>&nbsp;<font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/AYI' title='Acuity Brands, Inc. &#40;Holding Company&#41;'>AYI</a>&nbsp;<font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ODT' title='Odonate Therapeutics, Inc.'>ODT</a>&nbsp;<font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3341051\" data-linked=\"Midday Gainers / Losers (03/22/2018)\" data-tweet=\"$OMEX $OMEX $OMER - Midday Gainers / Losers (03/22/2018) https://seekingalpha.com/news/3341051-midday-gainers-losers-03-22-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3341051-midday-gainers-losers-03-22-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341048\" data-ts=\"1521736034\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMMX\" target=\"_blank\">AMMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341048-ameramex-closes-4_25m-equipment-order-shares-up-16\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AmeraMex closes $4.25M equipment order; shares up 16%</a></h4><ul><li>Thinly traded nano cap AmeraMex International (<a href='https://seekingalpha.com/symbol/AMMX' title='AmeraMex International Inc.'>OTCPK:AMMX</a> <font color='green'>+16.2%</font>) is up on a 17x surge in volume on the heels of its <a href=\"https://seekingalpha.com/pr/17109877-ameramex-international-receives-4_25-million-order\" target=\"_blank\">announcement </a>that it has received a $4.25M order for Taylor Machine Works forklifts. The equipment should ship in Q4.</li></ul><div class=\"tiny-share-widget\" data-id=\"3341048\" data-linked=\"AmeraMex closes $4.25M equipment order; shares up 16%\" data-tweet=\"$AMMX - AmeraMex closes $4.25M equipment order; shares up 16% https://seekingalpha.com/news/3341048-ameramex-closes-4_25m-equipment-order-shares-up-16?source=tweet\" data-url=\"https://seekingalpha.com/news/3341048-ameramex-closes-4_25m-equipment-order-shares-up-16\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341047\" data-ts=\"1521735503\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABBV\" target=\"_blank\">ABBV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341047-abbvie-down-14-on-softer-views-of-rov-t-trial-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AbbVie down 14% on softer views of Rov-T trial data</a></h4><ul><li>The broad market's down day notwithstanding, AbbVie (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color='red'>-13.6%</font>) continues to be under pressure after announcing disappointing Phase 2 data on Rova-T in third-line SCLC.</li><li>The company reported a 16% overall response rate &#40;ORR&#41;, but Endpoints' <a href=\"https://endpts.com/abbvie-shares-tank-on-rova-t-flop-retreat-from-accelerated-approval-pitch/\" target=\"_blank\">John Carroll says</a> the company admitted that the result was from a subgroup of patients with high DLL-3 expression (74% of the treatment group), meaning that it is a virtual certainty that the ORR for the entire patient set was lower.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3340976-abbvie-backs-away-pursuing-accelerated-approval-rova-t-disappointing-mid-stage-data-third\" target=\"_blank\">Abbvie backs away from pursuing accelerated approval for Rova-T after disappointing mid-stage data in third-line lung cancer; shares down 7% premarket</a> (March 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3341047\" data-linked=\"AbbVie down 14% on softer views of Rov-T trial data\" data-tweet=\"$ABBV - AbbVie down 14% on softer views of Rov-T trial data https://seekingalpha.com/news/3341047-abbvie-down-14-on-softer-views-of-rov-t-trial-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3341047-abbvie-down-14-on-softer-views-of-rov-t-trial-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341043\" data-ts=\"1521734445\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGPI\" target=\"_blank\">MGPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341043-consumer-top-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 11:00 am</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MGPI' title='MGP Ingredients, Inc.'>MGPI</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, LTD.'>GIII</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/MLHR' title='Herman Miller, Inc.'>MLHR</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3341043\" data-linked=\"Consumer - Top Gainers / Losers as of 11:00 am\" data-tweet=\"$MGPI $MGPI $GIII - Consumer - Top Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3341043-consumer-top-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3341043-consumer-top-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341040\" data-ts=\"1521733528\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RTTR\" target=\"_blank\">RTTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341040-ritter-pharma-to-execute-1-10-reverse-stock-split-tomorrow\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ritter Pharma to execute 1:10 reverse stock split tomorrow</a></h4><ul><li>Ritter Pharmaceuticals (<a href='https://seekingalpha.com/symbol/RTTR' title='Ritter Pharmaceuticals'>RTTR</a> <font color='green'>+0.8%</font>) will <a href=\"https://seekingalpha.com/pr/17109918-ritter-pharmaceuticals-announces-1minus-10-reverse-stock-split\" target=\"_blank\">institute </a>a 1:10 reverse split of its common stock effective tomorrow, March 23. Afterward, the number of issued and outstanding shares will be 4,940,652.</li></ul><div class=\"tiny-share-widget\" data-id=\"3341040\" data-linked=\"Ritter Pharma to execute 1:10 reverse stock split tomorrow\" data-tweet=\"$RTTR - Ritter Pharma to execute 1:10 reverse stock split tomorrow https://seekingalpha.com/news/3341040-ritter-pharma-to-execute-1-10-reverse-stock-split-tomorrow?source=tweet\" data-url=\"https://seekingalpha.com/news/3341040-ritter-pharma-to-execute-1-10-reverse-stock-split-tomorrow\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341039\" data-ts=\"1521733394\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341039-ibm-accused-of-firing-older-employees-higher-rate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM accused of firing older employees at higher rate</a></h4><ul><li>        IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) <a href=\"https://features.propublica.org/ibm/ibm-age-discrimination-american-workers/\" target=\"_blank\">cut around 20K American employees</a> over the age of 40 in the last few years, according to a new investigation from <i>Pro Publica</i> and <i>Mother Jones</i>.</li><li>               The figure represented about 60% of IBM&rsquo;s total U.S. job cuts in that period.&nbsp;</li><li>               IBM got around publicly disclosing the mass layoffs by converting the cuts into voluntary retirements or resignations.&nbsp;</li><li>                  Some employees were fired for supposed &ldquo;performance issues&rdquo; but then rehired as a cheaper contract employee. Others were encouraged to apply for other roles in the company, but IBM advised hiring managers not to hire that person.    </li><li>               Employees were also pressured to sign agreements that they wouldn&rsquo;t go to court against IBM or discuss their experience.&nbsp;</li><li>               IBM&rsquo;s response: &ldquo;We are proud of our company and our employees&rsquo; ability to reinvent themselves era after era, while always complying with the law. Our ability to do this is why we are the only tech company that has not only survived but thrived for more than 100 years.&rdquo;&nbsp;</li><li>               Read the full report <a href=\"https://features.propublica.org/ibm/ibm-age-discrimination-american-workers/\" target=\"_blank\">here</a>.&nbsp;</li><li>               IBM shares are&nbsp;<font color='red'>down 2.1%</font>&nbsp;to $153.37.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3341039\" data-linked=\"IBM accused of firing older employees at higher rate\" data-tweet=\"$IBM - IBM accused of firing older employees at higher rate https://seekingalpha.com/news/3341039-ibm-accused-of-firing-older-employees-higher-rate?source=tweet\" data-url=\"https://seekingalpha.com/news/3341039-ibm-accused-of-firing-older-employees-higher-rate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>91&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341035\" data-ts=\"1521732598\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WOW\" target=\"_blank\">WOW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341035-wideopenwestminus-3_4-rbc-cuts-rating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WideOpenWest -3.4% as RBC cuts rating</a></h4><ul>   <li>WideOpenWest (NYSE:<a href='https://seekingalpha.com/symbol/WOW' title='WideOpenWest, Inc.'>WOW</a>) is <font color='red'>3.4% lower</font> after a cut to Sector Perform at RBC.</li>    <li>The firm has a price target of $10, implying 30% upside from yesterday's close.</li>    <li>After hitting its publicly traded low of $7.03 a week ago, shares have hung not far above that level, currently at $7.43.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3341035\" data-linked=\"WideOpenWest -3.4% as RBC cuts rating\" data-tweet=\"$WOW - WideOpenWest -3.4% as RBC cuts rating https://seekingalpha.com/news/3341035-wideopenwestminus-3_4-rbc-cuts-rating?source=tweet\" data-url=\"https://seekingalpha.com/news/3341035-wideopenwestminus-3_4-rbc-cuts-rating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341034\" data-ts=\"1521732387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGO\" target=\"_blank\">EGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341034-eldorado-goldminus-5-following-q4-loss-year-end-reserves-fell-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eldorado Gold -5% following Q4 loss; year-end reserves fell 10%</a></h4><ul>     <li>Eldorado Gold (<a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a> <font color='red'>-5.9%</font>) plunges after reporting a <a href=\"https://seekingalpha.com/news/3340884-eldorado-gold-eps-0_03\" target=\"_blank\">Q4 loss</a> and <a href=\"https://seekingalpha.com/pr/17109033-eldorado-gold-reports-results-technical-studies\" target=\"_blank\">technical studies</a> for its Kisladag, Lamaque and Skouries mines.</li>     <li>EGO says its adjusted Q4 loss came in at $400K compared to $2.9M in earnings in the year-ago quarter, citing lower sales volumes; Q4 production totaled nearly 83.9K oz., up slightly  from 82.8K in  the same period a year ago, but oz. sold  fell 20% Y/Y to 67.3K from  84.6K.</li><li>Full-year gold production of 293K oz., including Olympias   pre-commercial production and 7K oz. from a bulk sample at the  newly  acquired Lamaque project in Quebec, fell 6% Y/Y from 312.3K oz. in 2016.</li><li>For 2018, EGO expects to produce 290K-330K oz. of gold,  including pre-commercial output from Lamaque.</li><li>EGO says it  ended 2017 with proven and probable gold reserves of 392M metric tons at  1.37 grams/ton gold containing 17.3M oz.; the company says the 10% overall  reduction in reserve oz. was attributable to the  planned  conversion of Kisladag from a heap-leach asset to a  mill-processing option, with  resulting higher processing costs and  higher recoveries.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3341034\" data-linked=\"Eldorado Gold -5% following Q4 loss; year-end reserves fell 10%\" data-tweet=\"$EGO - Eldorado Gold -5% following Q4 loss; year-end reserves fell 10% https://seekingalpha.com/news/3341034-eldorado-goldminus-5-following-q4-loss-year-end-reserves-fell-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3341034-eldorado-goldminus-5-following-q4-loss-year-end-reserves-fell-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>52&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341031\" data-ts=\"1521731762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SWIR\" target=\"_blank\">SWIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341031-sierra-wireless-to-provide-service-in-new-vending-solutions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sierra Wireless to provide service in new vending solutions</a></h4><ul>   <li>Sierra Wireless (<a href=\"http://seekingalpha.com/symbol/SWIR\" target=\"_blank\">SWIR</a> <font color='red'>-2.1%</font>) says its <a href=\"https://seekingalpha.com/pr/17109565-international-vending-alliance-selects-sierra-wireless-iot-services-revolutionize-vending\" target=\"_blank\">Internet of Things services</a> have been chosen by the Inernational Vending Alliance to revamp vending delivery.</li>    <li>A smart \"black box\" vending solution powered by Sierra Wireless allows for cashless payment, touch screens, targeted ads, online monitoring and more efficient management.</li>    <li>Data provided by machines will provide preventive maintenance, restocking optimizing and more services.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3341031\" data-linked=\"Sierra Wireless to provide service in new vending solutions\" data-tweet=\"$SWIR - Sierra Wireless to provide service in new vending solutions https://seekingalpha.com/news/3341031-sierra-wireless-to-provide-service-in-new-vending-solutions?source=tweet\" data-url=\"https://seekingalpha.com/news/3341031-sierra-wireless-to-provide-service-in-new-vending-solutions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341030\" data-ts=\"1521731717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UPLD\" target=\"_blank\">UPLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341030-upload-software-acquires-cloud-messaging-company-revises-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Upload Software acquires cloud messaging company, revises guidance</a></h4><ul><li>        Upland Software (NASDAQ:<a href='https://seekingalpha.com/symbol/UPLD' title='Upland Software'>UPLD</a>) <a href=\"https://investor.uplandsoftware.com/2018-03-22-Upland-Software-Announces-First-Acquisition-in-Europe-Raises-Guidance\" target=\"_blank\">acquires</a> InterFA Communications, a provider of secure cloud-based messaging solutions, for $37M in cash at closing.</li><li>                  Upland will also pay a $5M cash holdback over 18 months.    </li><li>               The acquisition is Upland&rsquo;s first in Europe and will add $15M in annualized recurring revenues. The deal will be immediately accretive to adjusted EBITDA per share.&nbsp;</li><li>                  Upland amends its credit facility from $200M to $258.7M.    </li><li>               The company also raises its FY18 guidance with revenue between $131M and $135M and subscription and support revenue from $118.4M to $121.6M. Adjusted EBITDA expected from $46.5M and $48.5M.&nbsp;</li><li>               Upland shares are&nbsp;<font color='green'>up 1.1%</font>&nbsp;to $29.58.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3341030\" data-linked=\"Upload Software acquires cloud messaging company, revises guidance\" data-tweet=\"$UPLD - Upload Software acquires cloud messaging company, revises guidance https://seekingalpha.com/news/3341030-upload-software-acquires-cloud-messaging-company-revises-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3341030-upload-software-acquires-cloud-messaging-company-revises-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341026\" data-ts=\"1521731289\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GAIA\" target=\"_blank\">GAIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341026-gaia-prices-stock-offering-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gaia prices stock offering at $15</a></h4><ul><li>Gaia (<a href='https://seekingalpha.com/symbol/GAIA' title='Gaia Inc.'>GAIA</a> <font color='red'>-3.9%</font>) <a href=\"https://seekingalpha.com/pr/17109599-gaia-announces-pricing-public-offering-class-common-stock\" target=\"_blank\">prices </a>its public offering of ~2.3M shares of Class A common stock at $15 per share. Underwriters over-allotment is an additional 350K shares. Closing date is March 26.</li><li>Corporate executives have agreed to purchase an aggregate of 134,733 shares in the offering.</li><li>Net proceeds of ~$32.3M will be used for general corporate purposes.</li><li>Yesterday's close was $16.10.</li></ul><div class=\"tiny-share-widget\" data-id=\"3341026\" data-linked=\"Gaia prices stock offering at $15\" data-tweet=\"$GAIA - Gaia prices stock offering at $15 https://seekingalpha.com/news/3341026-gaia-prices-stock-offering-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3341026-gaia-prices-stock-offering-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341022\" data-ts=\"1521730829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSC-OLD\" target=\"_blank\">SSC-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341022-seven-stars-cloud-raising-40m-in-private-placement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seven Stars Cloud raising $40M in private placement</a></h4><ul>   <li>Seven Stars Cloud (<a href=\"http://seekingalpha.com/symbol/SSC\" target=\"_blank\">SSC</a> <font color='green'>+4%</font>) has set a purchase agreement to <a href=\"https://seekingalpha.com/pr/17109668-seven-stars-cloud-raise-aggregate-40-million-usd-strategic-private-placement-gt-dollar\" target=\"_blank\">raise $40M from GT Dollar</a>, a Singaporean virtual credit clearing system operator, in a strategic private placement.</li>    <li>GT Dollar will get more than 13.773M shares of SSC common stock along with two convertible promissory notes. The stock comes at $1.82/share, and that payment of $25.07M will be funded before the end of the month.</li>    <li>One promissory note is for $10M and the other for $4.93M; on certain conditions those are convertible into SSC common stock at the rate of $1.82/share. GT Dollar is funding the $4.93M by the end of this month and $10M by April 30.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3341022\" data-linked=\"Seven Stars Cloud raising $40M in private placement\" data-tweet=\"$SSC-OLD - Seven Stars Cloud raising $40M in private placement https://seekingalpha.com/news/3341022-seven-stars-cloud-raising-40m-in-private-placement?source=tweet\" data-url=\"https://seekingalpha.com/news/3341022-seven-stars-cloud-raising-40m-in-private-placement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341021\" data-ts=\"1521730817\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMER\" target=\"_blank\">OMER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341021-healthcare-top-5-gainers-losers-of-11-00-3-22-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am (3/22/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='green'>+36%</font>. <a href='https://seekingalpha.com/symbol/EARS' title='Auris Medical Holding'>EARS</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/GERN' title='Geron Corporation'>GERN</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/SNGX' title='Soligenix, Inc.'>SNGX</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/TTNP' title='Titan Pharmaceuticals, Inc.'>TTNP</a> <font color='green'>+17%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/BGNE' title='BeiGene'>BGNE</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/GLYC' title='GlycoMimetics'>GLYC</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3341021\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am (3/22/2018)\" data-tweet=\"$OMER $OMER $EARS - Healthcare - Top 5 Gainers / Losers as of 11:00 am (3/22/2018) https://seekingalpha.com/news/3341021-healthcare-top-5-gainers-losers-of-11-00-3-22-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3341021-healthcare-top-5-gainers-losers-of-11-00-3-22-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341016\" data-ts=\"1521730005\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EARS\" target=\"_blank\">EARS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341016-auris-updates-on-development-activities-shares-up-25\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Auris updates on development activities; shares up 25%</a></h4><ul><li>Nano cap Auris Medical (<a href='https://seekingalpha.com/symbol/EARS' title='Auris Medical Holding'>EARS</a> <font color='green'>+24.5%</font>) is up on 30% higher volume in early trade. Shares were briefly up over&nbsp;<font color='green'>100%</font>&nbsp;before retracing on the heels of its <a href=\"https://seekingalpha.com/pr/17109690-auris-medical-provides-business-update-reports-fourth-quarter-full-year-2017-financial\" target=\"_blank\">business update</a> to investors. Key points:</li><li>AM-125: Results from Phase 1 study to determine maximum tolerated dose and additional bioavailability data of intranasal betahistine expected mid-year.</li><li>AM-111: Discussions initiated with European authorities seeking clarity for required data and regulatory pathway. Discussions with FDA to start in Q2. Data from 31 patients in the ASSENT study should be release by month-end (ASSENT is the sister trial of HEALOS).</li><li>Keyzilen (AM-101): Data analysis ongoing. Update when feasible.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3314680-auris-medicalsminus-111-flunks-late-stage-study-acute-inner-ear-hearing-loss-shares-49\" target=\"_blank\">Auris Medical's AM-111 flunks late-stage study in acute inner ear hearing loss; shares down 49% premarket</a> (Nov. 28, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3341016\" data-linked=\"Auris updates on development activities; shares up 25%\" data-tweet=\"$EARS - Auris updates on development activities; shares up 25% https://seekingalpha.com/news/3341016-auris-updates-on-development-activities-shares-up-25?source=tweet\" data-url=\"https://seekingalpha.com/news/3341016-auris-updates-on-development-activities-shares-up-25\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341015\" data-ts=\"1521729700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JKS\" target=\"_blank\">JKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341015-jinkosolarminus-7-gross-margin-continues-steady-slide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JinkoSolar -7% as gross margin continues steady slide</a></h4><ul>     <li>JinkoSolar (<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a> <font color='red'>-9.3%</font>) is sharply lower despite reporting better than expected <a href=\"https://seekingalpha.com/news/3340921-jinkosolar-holding-beats-0_03-beats-revenue\" target=\"_blank\">Q4 earnings</a> and a 24% Y/Y rise in revenue, as gross margin fell steadily to 11.6% from 12.0% in Q3 and 14.3% in the year-ago quarter.</li>     <li>Q4 solar module shipments totaled 2,481 MW, up 4.5% Q/Q and a 43% increase from 1,733 MW in the year-ago quarter.</li>     <li>For the full year, JKS says shipments of 9,807 MW rose 47% Y/Y but <a href=\"https://www.pv-magazine.com/2018/03/22/jinko-posts-strong-increase-in-shipments-for-2017-but-lower-profits/\" target=\"_blank\">gross profit fell 22.7%</a> to 2.99B CNY ($459.8M) from 3.87B CNY in the previous year, and gross margin fell to 11.3% from 18.1%, citing lower module ASPs, higher polysilicon prices and increasing production  volumes from OEM partners; total operating expenses for 2017 rose 5.8% Y/Y to 2.67B CNY ($409.8M), due to higher shipping costs and warranty costs.</li>     <li>JKS estimates total solar module shipments of 1.8-2.0 GW for Q1 and 11.5-12.0 GW for FY 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3341015\" data-linked=\"JinkoSolar -7% as gross margin continues steady slide\" data-tweet=\"$JKS - JinkoSolar -7% as gross margin continues steady slide https://seekingalpha.com/news/3341015-jinkosolarminus-7-gross-margin-continues-steady-slide?source=tweet\" data-url=\"https://seekingalpha.com/news/3341015-jinkosolarminus-7-gross-margin-continues-steady-slide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341005\" data-ts=\"1521728327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341005-yields-and-stocks-lower-trump-expected-to-impose-50b-tariffs-on-china\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yields and stocks both lower as Trump expected to impose $50B tariffs on China</a></h4><ul><li>S&amp;P 500 is down nearly 1%, and 10-year yields lower by 8-10 bps across the curve as investors fret Trump's trade policy.</li><li>Speculation is on the rise that China will retaliate to President Trump's tariffs expected to be announced today, <a href=\"https://www.bloomberg.com/news/articles/2018-03-21/asian-stocks-face-mixed-start-dollar-sinks-on-fed-markets-wrap\" target=\"_blank\">according a report on</a><a href=\"https://www.bloomberg.com/news/articles/2018-03-21/asian-stocks-face-mixed-start-dollar-sinks-on-fed-markets-wrap\" target=\"_blank\">&nbsp;Bloomberg</a>.</li><li>This comes after a reassuring read from the Fed yesterday that it is in no hurry to raise rates.</li><li>ETF's: <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a> up&nbsp;<font color='green'>1%</font>, and <a href='https://seekingalpha.com/symbol/SPY' title='SPDR S&P 500 Trust ETF'>SPY</a> down <font color='red'>0.7%.</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3341005\" data-linked=\"Yields and stocks both lower as Trump expected to impose $50B tariffs on China\" data-tweet=\"$TLT $SPY - Yields and stocks both lower as Trump expected to impose $50B tariffs on China https://seekingalpha.com/news/3341005-yields-and-stocks-lower-trump-expected-to-impose-50b-tariffs-on-china?source=tweet\" data-url=\"https://seekingalpha.com/news/3341005-yields-and-stocks-lower-trump-expected-to-impose-50b-tariffs-on-china\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3341007\" data-ts=\"1521728011\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXL\" target=\"_blank\">AXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3341007-american-axle-borgwarner-higher-after-double-upgrades-morgan-stanley\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Axle, BorgWarner higher after double-upgrades at Morgan Stanley</a></h4><ul>     <li>American Axle (<a href='https://seekingalpha.com/symbol/AXL' title='American Axle & Manufacturing Holdings, Inc.'>AXL</a> <font color='green'>+3.7%</font>) and BorgWarner (<a href='https://seekingalpha.com/symbol/BWA' title='BorgWarner Inc.'>BWA</a> <font color='green'>+1.9%</font>) jump to early gains after Morgan Stanley awards <a href=\"https://thefly.com/thestreet/realmoney/index.php/AXL%3bBWAid2702869/AXL%3bBWA-Morgan-Stanley-sees-room-left-for-Auto--double-upgrades-American-Axle-BorgWarner\" target=\"_blank\">two-notch upgrades</a> of each to Overweight from Underweight with respective $21 and $61 price targets.</li>     <li>Stanley says the auto industry is going through an \"unprecedented period of cyclical and secular change\" and investors are currently skewed negative on U.S. autos and shared mobility stocks, but it sees \"more road left for Auto 1.0\" suppliers.</li>     <li>The firm thinks AXL shares have the potential to re-rate as free cash flow is used to delever and BWA may enjoy positive guidance revisions in the near term.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3341007\" data-linked=\"American Axle, BorgWarner higher after double-upgrades at Morgan Stanley\" data-tweet=\"$AXL $AXL $BWA - American Axle, BorgWarner higher after double-upgrades at Morgan Stanley https://seekingalpha.com/news/3341007-american-axle-borgwarner-higher-after-double-upgrades-morgan-stanley?source=tweet\" data-url=\"https://seekingalpha.com/news/3341007-american-axle-borgwarner-higher-after-double-upgrades-morgan-stanley\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340995\" data-ts=\"1521726456\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTL\" target=\"_blank\">VTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340995-vital-therapies-completes-enrollment-in-late-stage-study-of-elad-in-patients-severe-hepatitis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vital Therapies completes enrollment in late-stage study of ELAD in patients with severe hepatitis</a></h4><ul><li>Vital Therapies (<a href='https://seekingalpha.com/symbol/VTL' title='Vital Therapies, Inc.'>VTL</a> <font color='red'>-3.4%</font>) completes the <a href=\"https://seekingalpha.com/pr/17109431-vital-therapies-announces-vtlminus-308-reaches-enrollment-target-150-subjects\" target=\"_blank\">enrollment </a>of 150 subjects in a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02612428?intr=elad&amp;spons=vital+therapies&amp;phase=2&amp;rank=2\" target=\"_blank\">VTL-308</a>, assessing cell therapy ELAD in patients with severe alcoholic hepatitis.</li><li>The primary endpoint is overall survival. Topline data should be available in Q3.</li><li><a href=\"http://humanvitaltherapies.com/elad/technology/\" target=\"_blank\">ELAD&nbsp;</a>is an extracorporeal (outside the body) human cell-based support system designed to supplement liver function and improve survival rates in liver failure patients.</li><li>Previously: <a href=\"https://seekingalpha.com/news/2741866-vital-therapies-elad-system-fails-late-stage-study\" target=\"_blank\">Vital Therapies' ELAD system fails in late stage study</a> (Aug. 21, 2015)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340995\" data-linked=\"Vital Therapies completes enrollment in late-stage study of ELAD in patients with severe hepatitis\" data-tweet=\"$VTL $IMUX - Vital Therapies completes enrollment in late-stage study of ELAD in patients with severe hepatitis https://seekingalpha.com/news/3340995-vital-therapies-completes-enrollment-in-late-stage-study-of-elad-in-patients-severe-hepatitis?source=tweet\" data-url=\"https://seekingalpha.com/news/3340995-vital-therapies-completes-enrollment-in-late-stage-study-of-elad-in-patients-severe-hepatitis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340993\" data-ts=\"1521726171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIRI\" target=\"_blank\">SIRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340993-citi-downgrades-sirius-xm-likes-liberty-sirius\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi downgrades Sirius XM, but likes Liberty Sirius</a></h4><ul>   <li>Sirius XM (<a href=\"http://seekingalpha.com/symbol/SIRI\" target=\"_blank\">SIRI</a> <font color='red'>-1%</font>) is lower out of the open after a downgrade to Neutral at Citigroup.</li>    <li>The firm is struggling to see how Sirius can pass a price target of $6.65 over the next 12 to 18 months, it says.</li>    <li>But it's staying in the unanimous bullish camp on Liberty Sirius (<a href=\"http://seekingalpha.com/symbol/LSXMA\" target=\"_blank\">LSXMA</a> <font color='red'>-1.2%</font>), which it says has a 30% discount to NAV that the company will likely close by buying Pandora (<a href=\"http://seekingalpha.com/symbol/P\" target=\"_blank\">P</a> <font color='green'>+7.8%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340993\" data-linked=\"Citi downgrades Sirius XM, but likes Liberty Sirius\" data-tweet=\"$SIRI $SIRI $LSXMA - Citi downgrades Sirius XM, but likes Liberty Sirius https://seekingalpha.com/news/3340993-citi-downgrades-sirius-xm-likes-liberty-sirius?source=tweet\" data-url=\"https://seekingalpha.com/news/3340993-citi-downgrades-sirius-xm-likes-liberty-sirius\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340988\" data-ts=\"1521725343\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRO\" target=\"_blank\">GPRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340988-gopro-and-jabil-strike-deal-for-tech-in-third-party-devices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GoPro and Jabil strike deal for tech in third-party devices</a></h4><ul><li>        GoPro (NASDAQ:<a href='https://seekingalpha.com/symbol/GPRO' title='GoPro'>GPRO</a>) <a href=\"https://seekingalpha.com/pr/17109627-gopro-jabil-announce-global-technology-equipment-license\" target=\"_blank\">announces</a> a multi-year deal with Jabil (NYSE:<a href='https://seekingalpha.com/symbol/JBL' title='Jabil Inc.'>JBL</a>) to put GoPro tech in a range of products potentially including police cameras, video conferencing solutions, and self-driving cars.</li><li>               Jabil will use GoPro&rsquo;s design and IP in third-party devices, which marks the first time GoPro allowed other manufacturers to build using its supplies.&nbsp;</li><li>               GoPro shares are&nbsp;<font color='red'>down 0.8%</font>&nbsp;premarket to $4.88 and&nbsp;<font color='red'>down 41%&nbsp;</font>in the past year. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3340988\" data-linked=\"GoPro and Jabil strike deal for tech in third-party devices\" data-tweet=\"$GPRO $GPRO $JBL - GoPro and Jabil strike deal for tech in third-party devices https://seekingalpha.com/news/3340988-gopro-and-jabil-strike-deal-for-tech-in-third-party-devices?source=tweet\" data-url=\"https://seekingalpha.com/news/3340988-gopro-and-jabil-strike-deal-for-tech-in-third-party-devices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340990\" data-ts=\"1521725323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TELL\" target=\"_blank\">TELL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340990-tellurianplus-5-bechtel-makes-50m-preferred-equity-investment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tellurian +5% as Bechtel makes $50M preferred equity investment</a></h4><ul>     <li>Tellurian (NASDAQ:<a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a>) <font color='green'>+5%</font> premarket on news that engineering giant Bechtel made a       <a href=\"https://seekingalpha.com/pr/17108810-bechtel-makes-50-million-investment-tellurian\" target=\"_blank\">$50M zero coupon preferred equity investment</a> in the company which       has an implied stock price of $8.16/share.</li><li>\"Bechtel and Tellurian management       have constructed 55M tonnes per annum of liquefaction       capacity together on various projects and have formed a respected and       productive relationship,\"&nbsp;TELL says.</li>     <li>Last November, the two companies signed four fixed-price, lump sum turnkey agreements totaling $15.2B for EPC of Driftwood, an LNG export facility proposed near Lake Charles, La.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340990\" data-linked=\"Tellurian +5% as Bechtel makes $50M preferred equity investment\" data-tweet=\"$TELL - Tellurian +5% as Bechtel makes $50M preferred equity investment https://seekingalpha.com/news/3340990-tellurianplus-5-bechtel-makes-50m-preferred-equity-investment?source=tweet\" data-url=\"https://seekingalpha.com/news/3340990-tellurianplus-5-bechtel-makes-50m-preferred-equity-investment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340984\" data-ts=\"1521725191\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDUS\" target=\"_blank\">RDUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340984-negative-vote-in-europe-for-radius-healths-osteoporosis-candidate-abaloparatide-shares-down-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Negative vote in Europe for Radius Health&#39;s osteoporosis candidate abaloparatide; shares down 5% premarket</a></h4><ul><li>Radius Health (NASDAQ:<a href='https://seekingalpha.com/symbol/RDUS' title='Radius Health, Inc.'>RDUS</a>) is down&nbsp;<font color='red'>5%</font>&nbsp;premarket on the heels of its <a href=\"https://seekingalpha.com/pr/17109636-radius-health-provides-update-chmp-opinion-abaloparatide-sc\" target=\"_blank\">announcement</a> that the European Medicines Agency's Committee for Medicinal Products for Human Use &#40;CHMP&#41; will adopt a negative opinion against recommending approval for abaloparatide-SC for the treatment of osteoporosis in postmenopausal women at increased risk of fracture.</li><li>The company says it will appeal the decision and immediately seek a re-examination of CHMP's opinion.</li><li>Abaloparatide, branded as TYMLOS, was approved in the U.S. about a year ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3318575-radius-health-quite-european-marketing-application-osteoporosis-med-abaloparatide-shares-3\" target=\"_blank\">Radius Health not quite there with European marketing application for osteoporosis med abaloparatide; shares down 3% premarket</a> (Dec. 15, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340984\" data-linked=\"Negative vote in Europe for Radius Health&#39;s osteoporosis candidate abaloparatide; shares down 5% premarket\" data-tweet=\"$RDUS - Negative vote in Europe for Radius Health&#39;s osteoporosis candidate abaloparatide; shares down 5% premarket https://seekingalpha.com/news/3340984-negative-vote-in-europe-for-radius-healths-osteoporosis-candidate-abaloparatide-shares-down-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3340984-negative-vote-in-europe-for-radius-healths-osteoporosis-candidate-abaloparatide-shares-down-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340983\" data-ts=\"1521725040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFEC\" target=\"_blank\">NFEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340983-premarket-losers-of-9-05-03-22-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (03/22/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/NFEC' title='NF Energy Saving Corp.'>NFEC</a>&nbsp;<font color='red'>-21%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17109631-nf-energy-signed-securities-purchase-agreement\" target=\"_blank\">signing</a> securities purchase agreement.</li><li><a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a>&nbsp;<font color='red'>-7%</font>&nbsp;as it <a href=\"https://seekingalpha.com/news/3340976-abbvie-backs-away-pursuing-accelerated-approval-rova-t-disappointing-mid-stage-data-third\" target=\"_blank\">backs away</a> from pursuing accelerated approval for Rova-T after disappointing mid-stage data in third-line lung cancer.</li><li><a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a>&nbsp;<font color='red'>-7%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3340884-eldorado-gold-eps-0_03\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/CALI' title='China Auto Logistics Inc.'>OTC:CALI</a>&nbsp;<font color='red'>-6%</font>.</li><li><a href='https://seekingalpha.com/symbol/ARNA' title='Arena Pharmaceuticals, Inc.'>ARNA</a>&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3340877-arena-pharmaceuticals-minus-2_2-percent-pricing-8_5m-share-offering\" target=\"_blank\">pricing</a> 8.5M-share offering</li><li><a href='https://seekingalpha.com/symbol/MIK' title='The Michaels Companies'>MIK</a>&nbsp;<font color='red'>-6%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3340920-michaels-companies-eps-line-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, LTD.'>GIII</a>&nbsp;<font color='red'>-5%</font>&nbsp;on Q4&nbsp;<a href=\"https://seekingalpha.com/news/3340919-g-iii-apparel-beats-0_09-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/DRI' title='Darden Restaurants, Inc.'>DRI</a>&nbsp;<font color='red'>-5%</font>&nbsp;on Q4&nbsp;<a href=\"https://seekingalpha.com/news/3340922-darden-restaurants-beats-0_07-misses-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/GAIA' title='Gaia Inc.'>GAIA</a>&nbsp;<font color='red'>-5%</font>&nbsp;on stock <a href=\"https://seekingalpha.com/news/3340820-gaia-launches-stock-offering\" target=\"_blank\">offering</a>.</li><li><a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a>&nbsp;<font color='red'>-5%</font>&nbsp;on $100M <a href=\"https://seekingalpha.com/pr/17109014-c-o-r-r-e-c-t-o-n-source-cronos-group-inc\" target=\"_blank\">deal</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340983\" data-linked=\"Premarket Losers as of 9:05 am (03/22/2018)\" data-tweet=\"$NFEC $BIMI $ABBV - Premarket Losers as of 9:05 am (03/22/2018) https://seekingalpha.com/news/3340983-premarket-losers-of-9-05-03-22-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3340983-premarket-losers-of-9-05-03-22-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340982\" data-ts=\"1521725027\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340982-pandoraplus-5_7-on-two-notch-upgrade-raymond-james\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora +5.7% on two-notch upgrade at Raymond James</a></h4><ul>   <li>Pandora Media (NYSE:<a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a>) is <font color='green'>up 5.7%</font> premarket after a two-notch upgrade at Raymond James, to Strong Buy.</li>    <li>The change is from a previous Market Perform stance after the company announced its $145M <a href=\"https://seekingalpha.com/news/3340726-pandora-buy-ad-tech-firm-adswizz-145m-shares-plus-1_5-percent\" target=\"_blank\">purchase of ad-tech firm AdsWizz</a>, a deal that takes pressure off of quarterly user trends, it says.</li>    <li>The deal is of a piece with Google's strategy when it bought DoubleClick, analyst Justin Patterson says, in creating a platform for publishers to monetize audio.</li>    <li>He has a price target of $8, implying 63% upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340982\" data-linked=\"Pandora +5.7% on two-notch upgrade at Raymond James\" data-tweet=\"$P - Pandora +5.7% on two-notch upgrade at Raymond James https://seekingalpha.com/news/3340982-pandoraplus-5_7-on-two-notch-upgrade-raymond-james?source=tweet\" data-url=\"https://seekingalpha.com/news/3340982-pandoraplus-5_7-on-two-notch-upgrade-raymond-james\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340976\" data-ts=\"1521724501\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABBV\" target=\"_blank\">ABBV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340976-abbvie-backs-away-from-pursuing-accelerated-approval-for-rova-t-after-disappointing-mid-stage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abbvie backs away from pursuing accelerated approval for Rova-T after disappointing mid-stage data in third-line lung cancer; shares down 7% premarket</a></h4><ul><li>AbbVie (NYSE:<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a>) slips&nbsp;<font color='red'>7%</font>&nbsp;premarket on the heels of its <a href=\"https://seekingalpha.com/pr/17109526-abbvie-announces-results-phase-2-study-evaluating-rovalpituzumab-tesirine-rova-t-third-line\" target=\"_blank\">announcement </a>that it will not seek accelerated approval for antibody-drug conjugate Rova-T (rovalpituzumab tesirine) in third-line relapsed/refractory small cell lung cancer &#40;SCLC&#41;. The company made its decision after consulting with the FDA on results from a single-arm Phase 2 study, TRINITY, that apparently failed demonstrate enough of a treatment benefit to support accelerated approval.</li><li>EVP of R&amp;D and CSO Mike Severino, M.D., says, \"We continue to believe Rova-T has potential for patients with small cell lung cancer and other DLL3-expressing cancers. Although the results from the study were not what we hoped for, we look forward to receiving data from the ongoing Phase 3 studies in the first- and second-line settings and remain committed to developing Rova-T for the treatment of patients with small cell lung cancer.\"</li><li>Top-line data from TRINITY showed a 16% overall response rate &#40;ORR&#41;&nbsp;and a median duration of response of 4.1 months.</li><li>On the safety front, the most frequent treatment-emergent adverse events were fatigue (38%), photosensitivity reaction (36%), pleural effusion (fluid buildup in the lungs) (32%), peripheral edema (31%), decreased appetite (30%), nausea (26%) and dyspnea (difficulty breathing) (25%).</li><li><strong>Update</strong>: John Carroll <a href=\"https://endpts.com/abbvie-shares-tank-on-rova-t-flop-retreat-from-accelerated-approval-pitch/\" target=\"_blank\">reports </a>that the market was expecting an ORR of 40% , adding that chem combo regimens deliver ~20% response rates.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340976\" data-linked=\"Abbvie backs away from pursuing accelerated approval for Rova-T after disappointing mid-stage data in third-line lung cancer; shares down 7% premarket\" data-tweet=\"$ABBV - Abbvie backs away from pursuing accelerated approval for Rova-T after disappointing mid-stage data in third-line lung cancer; shares down 7% premarket https://seekingalpha.com/news/3340976-abbvie-backs-away-from-pursuing-accelerated-approval-for-rova-t-after-disappointing-mid-stage?source=tweet\" data-url=\"https://seekingalpha.com/news/3340976-abbvie-backs-away-from-pursuing-accelerated-approval-for-rova-t-after-disappointing-mid-stage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>65&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340979\" data-ts=\"1521724474\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340979-wsj-whole-foods-execs-keep-leaving-amazon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: Whole Foods execs keep leaving Amazon</a></h4><ul><li>        Over a dozen execs and senior managers have left since Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) purchased Whole Foods, according to a <a href=\"https://www.wsj.com/articles/whole-foods-is-losing-executives-under-new-owner-amazon-1521711002?mod=rss_Technology\" target=\"_blank\">WSJ report</a>.</li><li>               Departing execs have headed bakery, produce, and local-foods divisions. Some left, even after higher-ups asked them to stay, while others were pushed out before the deal closed.&nbsp;</li><li>               What&rsquo;s driving workers out? Some top managers oppose reporting to younger Amazon execs while others say Amazon hasn&rsquo;t properly explained how it will integrate Whole Foods into its business.&nbsp;</li><li>               Exec departures aren&rsquo;t uncommon after mergers. Amazon has invited employees to town halls to discuss concerns and this week held an event for suppliers.&nbsp;</li><li>               Amazon shares are&nbsp;<font color='red'>down 1.3%</font>&nbsp;premarket.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3340860-recode-uber-withdraws-job-offer-amazon-voice-shopping-exec\" target=\"_blank\">Recode: Uber withdraws job offer to Amazon voice shopping exec</a> (March 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340979\" data-linked=\"WSJ: Whole Foods execs keep leaving Amazon\" data-tweet=\"$AMZN - WSJ: Whole Foods execs keep leaving Amazon https://seekingalpha.com/news/3340979-wsj-whole-foods-execs-keep-leaving-amazon?source=tweet\" data-url=\"https://seekingalpha.com/news/3340979-wsj-whole-foods-execs-keep-leaving-amazon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>71&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340978\" data-ts=\"1521724415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRUE\" target=\"_blank\">TRUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340978-truecar-on-track-for-16-month-low-after-j-p-morgan-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TrueCar on track for 16-month low after J.P. Morgan downgrade</a></h4><ul>     <li>TrueCar (NASDAQ:<a href='https://seekingalpha.com/symbol/TRUE' title='TrueCar, Inc'>TRUE</a>) <font color='red'>-4%</font> premarket on track to open at a 16-month low after J.P. Morgan <a href=\"https://www.marketwatch.com/story/truecars-stock-tumbles-toward-16-month-low-after-jp-morgan-turns-bearish-2018-03-22\" target=\"_blank\">downgrades</a> shares to Underweight from Neutral with a $10 price target, slashed from $13, citing weak auto industry trends and execution risk.</li><li>JPM's Doug Anmuth says he is concerned that industry light vehicle sales have declined 1% YTD and that dealers are turning cautious, as evidenced by dealership operator Group 1 Automotive's (NYSE:<a href='https://seekingalpha.com/symbol/GPI' title='Group 1 Automotive Inc.'>GPI</a>) warning <a href=\"https://seekingalpha.com/news/3340497-group-1-automotive-minus-9-percent-warning-q1-earnings\" target=\"_blank\">earlier this week</a> about weak market conditions and pressure on used car margins.</li><li>Anmuth says TRUE's investment in the Capsella project is a positive but the investments will take time to \"move the needle\" on earnings, and the firm is \"cautious around emerging headwinds in the auto industry that could weigh on near-term performance.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3340978\" data-linked=\"TrueCar on track for 16-month low after J.P. Morgan downgrade\" data-tweet=\"$TRUE $TRUE $GPI - TrueCar on track for 16-month low after J.P. Morgan downgrade https://seekingalpha.com/news/3340978-truecar-on-track-for-16-month-low-after-j-p-morgan-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3340978-truecar-on-track-for-16-month-low-after-j-p-morgan-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340977\" data-ts=\"1521724314\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMER\" target=\"_blank\">OMER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340977-premarket-gainers-of-9-05-03-22-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (03/22/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='green'>+60%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3340954-omeros-37-percent-premarket-continuation-omidria-pricing\" target=\"_blank\">continuation</a> Omidria pricing.</li>     <li><a href='https://seekingalpha.com/symbol/SNGX' title='Soligenix, Inc.'>SNGX</a> <font color='green'>+13%</font>&nbsp;as RiVax been <a href=\"https://seekingalpha.com/news/3340916-soligenixs-rivax-orphan-drug-europe\" target=\"_blank\">granted</a> orphan drug status by the European commission.</li>     <li><a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a> <font color='green'>+11%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3340839-guess-beats-0_08-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/MNGA' title='MagneGas Corporation'>MNGA</a> <font color='green'>+8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3340943-acquisitions-magnegas\" target=\"_blank\">purchase</a> of&nbsp;Trico Welding Supplies.</li>     <li><a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a> <font color='green'>+5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340977\" data-linked=\"Premarket Gainers as of 9:05 am (03/22/2018)\" data-tweet=\"$OMER $OMER $SNGX - Premarket Gainers as of 9:05 am (03/22/2018) https://seekingalpha.com/news/3340977-premarket-gainers-of-9-05-03-22-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3340977-premarket-gainers-of-9-05-03-22-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340969\" data-ts=\"1521723460\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAG\" target=\"_blank\">CAG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340969-organic-sales-declined-for-conagra-foods-in-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Organic sales declined for ConAgra Foods in Q3</a></h4><ul><li>ConAgra Foods (NYSE:<a href='https://seekingalpha.com/symbol/CAG' title='ConAgra Brands, Inc.'>CAG</a>) reports organic net sales declined 2.2% in <a href=\"https://seekingalpha.com/pr/17109279-conagra-brands-reports-net-sales-eps-growth-third-quarter\" target=\"_blank\">Q3</a>, reflecting reductions in retailer inventory levels.</li><li>Segment net sales:&nbsp;Grocery &amp; Snacks: $838M (-1%);&nbsp;Refrigerated &amp; Frozen: $689M (+3%);&nbsp;International: $223M (+9%);&nbsp;Foodservice: $224M (-6%).</li><li>Adjusted gross margin rate slipped 160 bps to 30%.</li><li>The company expects to repurchase ~$1.1B of shares of its common stock&nbsp;this year.</li><li><b>FY2018 Guidance</b>: Net sales: ~150 bps higher than the organic net sales growth rate; Organic net sales:&nbsp;near the high end of&nbsp;-2% to flat;&nbsp;Adjusted operating margin rate:&nbsp;low end of&nbsp;15.9% to 16.3%; Tax rate: 29% to 30%; Adjusted EPS: $2.03 to $2.05.</li><li>CAG&nbsp;<font color='green'>+1.87%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340969\" data-linked=\"Organic sales declined for ConAgra Foods in Q3\" data-tweet=\"$CAG - Organic sales declined for ConAgra Foods in Q3 https://seekingalpha.com/news/3340969-organic-sales-declined-for-conagra-foods-in-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3340969-organic-sales-declined-for-conagra-foods-in-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340967\" data-ts=\"1521723051\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VERU\" target=\"_blank\">VERU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340967-fda-waives-2_4m-fee-for-veru-nda-for-tamsulosin-drs-shares-up-22-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA waives $2.4M fee for Veru NDA for Tamsulosin DRS; shares up 22% premarket</a></h4><ul><li>Thinly traded micro cap Veru (NASDAQ:<a href='https://seekingalpha.com/symbol/VERU' title='Veru Inc.'>VERU</a>) is up&nbsp;<font color='green'>22%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17109477-fda-grants-fee-waiver-tamsulosin-drs-new-drug-application\" target=\"_blank\">announcement </a>that the FDA has waived the application fee of ~$2.4M for the company's New Drug Application &#40;NDA&#41; seeking approval for Tamsulosin Delayed Release Sachet &#40;DRS&#41;, a slow-release oral granule formulation for men with benign prostatic hyperplasia (enlarged prostate) who have difficulty swallowing tablets or capsules.</li><li>The company was spared the cost of the application under a small business waiver.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340967\" data-linked=\"FDA waives $2.4M fee for Veru NDA for Tamsulosin DRS; shares up 22% premarket\" data-tweet=\"$VERU - FDA waives $2.4M fee for Veru NDA for Tamsulosin DRS; shares up 22% premarket https://seekingalpha.com/news/3340967-fda-waives-2_4m-fee-for-veru-nda-for-tamsulosin-drs-shares-up-22-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3340967-fda-waives-2_4m-fee-for-veru-nda-for-tamsulosin-drs-shares-up-22-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340964\" data-ts=\"1521722646\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMC\" target=\"_blank\">CMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340964-commercial-metalsminus-4-after-missing-on-quarterly-earnings-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Commercial Metals -4% after missing on quarterly earnings, revenues</a></h4><ul>     <li>Commercial Metals (NYSE:<a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a>) <font color='red'>-3.9%</font> premarket after <a href=\"https://seekingalpha.com/news/3340912-commercial-metals-misses-0_01-misses-revenue\" target=\"_blank\">FQ2 earnings</a> and revenues both came in below analyst estimates, saying it experienced \"margin compression\" in its Americas mills and fabrication business, as raw materials costs rose faster than selling prices.</li>     <li>CMC says its Americas Mills segment recorded adjusted operating profit of $31.5M, including $8.7M in costs related to the start-up activities of the Durant, Okla., micro mill, compared to $51.3M in profit in the year-ago quarter; its Americas Fabrication segment posting a $27.1M operating loss, including a $12.1M asset impairment, vs. a slight profit a year ago.</li><li>CMC expects the Durant facility will be operating near its 350K tons/year capacity by the end of FY 2018.</li>     <li>\"Section 232 trade remedy details are still being finalized; however, we are hopeful that it will lead to a leveling of the playing field against imports,\" the company says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340964\" data-linked=\"Commercial Metals -4% after missing on quarterly earnings, revenues\" data-tweet=\"$CMC - Commercial Metals -4% after missing on quarterly earnings, revenues https://seekingalpha.com/news/3340964-commercial-metalsminus-4-after-missing-on-quarterly-earnings-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/3340964-commercial-metalsminus-4-after-missing-on-quarterly-earnings-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340960\" data-ts=\"1521722068\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNCR\" target=\"_blank\">SNCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340960-synchronossplus-8_4-on-verizon-deal-extension\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synchronoss +8.4% on Verizon deal extension</a></h4><ul><li>Synchronoss Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SNCR' title='Synchronoss Technologies, Inc.'>SNCR</a>) <a href=\"https://seekingalpha.com/pr/17109350-synchronoss-renews-agreement-power-verizon-cloud\" target=\"_blank\">renews</a> its existing agreement to power Verizon&rsquo;s Cloud solution for an additional five years.</li><li>The Synchronoss Personal Cloud Platform and solutions provide Verizon customers access to personal content from photos to messages from any device.</li><li>Synchronoss shares are&nbsp;<font color='green'>up 8.4%</font>&nbsp;premarket to $11.25.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340960\" data-linked=\"Synchronoss +8.4% on Verizon deal extension\" data-tweet=\"$SNCR - Synchronoss +8.4% on Verizon deal extension https://seekingalpha.com/news/3340960-synchronossplus-8_4-on-verizon-deal-extension?source=tweet\" data-url=\"https://seekingalpha.com/news/3340960-synchronossplus-8_4-on-verizon-deal-extension\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340954\" data-ts=\"1521721442\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMER\" target=\"_blank\">OMER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340954-omeros-up-37-premarket-on-continuation-omidria-pricing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Omeros up 37% premarket on continuation Omidria pricing</a></h4><ul><li>Omeros (NASDAQ:<a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a>) is up&nbsp;<font color='green'>37%</font>&nbsp;premarket on increased volume in response to the new <a href=\"http://docs.house.gov/billsthisweek/20180319/BILLS-115SAHR1625-RCP115-66.pdf\" target=\"_blank\">spending package</a> from the federal government that apparently allows the company to continue <a href=\"https://www.statnews.com/2018/03/21/omeros-pass-through/\" target=\"_blank\">charging Medicare</a> higher prices for cataract surgery med OMIDRIA (phenylephrine and ketorolac intraocular solution) for another two years.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340954\" data-linked=\"Omeros up 37% premarket on continuation Omidria pricing\" data-tweet=\"$OMER - Omeros up 37% premarket on continuation Omidria pricing https://seekingalpha.com/news/3340954-omeros-up-37-premarket-on-continuation-omidria-pricing?source=tweet\" data-url=\"https://seekingalpha.com/news/3340954-omeros-up-37-premarket-on-continuation-omidria-pricing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340953\" data-ts=\"1521721382\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340953-apples-new-iphones-enter-trial-production-in-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple&#39;s new iPhones could enter trial production in Q2</a></h4><ul><li>        Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) will enter trial production of its new iPhone series in Q2, according to <a href=\"https://www.digitimes.com/news/a20180322PD203.html\" target=\"_blank\">Digitimes sources</a>.</li><li>               Apple wants an early start to avoid the 3D sensor yield rate issues with last years models, which pushed back the launch date of the iPhone X.&nbsp;</li><li>               Apple could start delivering the new iPhones early in Q3, and that timeframe could start pushing up component maker revenues as early as Q2.&nbsp;</li><li>               Suppliers that could move on the news: Skyworks Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/SWKS' title='Skyworks Solutions, Inc.'>SWKS</a>), Cirrus Logic (NASDAQ:<a href='https://seekingalpha.com/symbol/CRUS' title='Cirrus Logic, Inc.'>CRUS</a>), Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>), Qorvo (NASDAQ:<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc'>QRVO</a>), Finisar (NASDAQ:<a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a>), II-VI (NASDAQ:<a href='https://seekingalpha.com/symbol/IIVI' title='II-VI Incorporated'>IIVI</a>), and Lumentum (NASDAQ:<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a>).&nbsp;</li><li>               Apple shares are&nbsp;<font color='red'>down 0.3%</font>&nbsp;premarket to $170.76.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3340725-new-iphone-x-cost-apple-10-percent-less-iovine-stepping-back-music\" target=\"_blank\">New iPhone X could cost Apple 10% less; Iovine stepping back from Music</a> (March 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340953\" data-linked=\"Apple&#39;s new iPhones could enter trial production in Q2\" data-tweet=\"$AAPL $AAPL $SWKS - Apple&#39;s new iPhones could enter trial production in Q2 https://seekingalpha.com/news/3340953-apples-new-iphones-enter-trial-production-in-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/3340953-apples-new-iphones-enter-trial-production-in-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340947\" data-ts=\"1521720245\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RETA\" target=\"_blank\">RETA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340947-reatas-bardoxolone-shows-treatment-effect-in-mid-stage-study-in-certain-pulmonary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reata&#39;s bardoxolone shows treatment effect in mid-stage study in certain pulmonary hypertension patients</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17109287-reata-announces-positive-top-line-data-treatment-ph-ild-bardoxolone-methyl-phase-2-lariat\" target=\"_blank\">Top-line results </a>from a Phase 2 clinical trial, LARIAT, evaluating Reata Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/RETA' title='Reata Pharmaceuticals'>RETA</a>) bardoxolone methyl in pulmonary hypertension &#40;PH&#41; patients with interstitial lung disease &#40;ILD&#41; showed a treatment benefit.</li><li>After a 16-week treatment period, patients receiving bardoxolone showed a statistically significant improvement in the six-minute walk test (6MWD) versus baseline (38 meters) compared to a 13-meter reduction for placebo.</li><li>In sarcoidosis patients, the increase in the 6MWD was 17 m compared to a 9 m increase for placebo.</li><li>The company says once it completes all of its ongoing Phase 2 studies it will determine the subsequent development steps.</li><li><a href=\"http://reatapharma.com/product-pipeline/cardiovascular/bardpulmonary-hypertension-ild-ctd/\" target=\"_blank\">Bardoxolone methyl</a>&nbsp;is an oral once-daily antioxidant inflammation modulator that targets the&nbsp;<a href=\"https://en.wikipedia.org/wiki/NFE2L2\" target=\"_blank\">Nrf2 pathway</a>, a regulator of antioxidant proteins that protect against oxidative damage associated with injury or inflammation.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3330339-reatas-bardoxolone-shows-long-term-effect-pah-patients-shares-ahead-23-percent-hours\" target=\"_blank\">Reata's bardoxolone shows long-term effect in PAH patients; shares ahead 23% after hours</a> (Feb. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340947\" data-linked=\"Reata&#39;s bardoxolone shows treatment effect in mid-stage study in certain pulmonary hypertension patients\" data-tweet=\"$RETA - Reata&#39;s bardoxolone shows treatment effect in mid-stage study in certain pulmonary hypertension patients https://seekingalpha.com/news/3340947-reatas-bardoxolone-shows-treatment-effect-in-mid-stage-study-in-certain-pulmonary?source=tweet\" data-url=\"https://seekingalpha.com/news/3340947-reatas-bardoxolone-shows-treatment-effect-in-mid-stage-study-in-certain-pulmonary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340928\" data-ts=\"1521717919\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACN\" target=\"_blank\">ACN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340928-accenture-reports-q2-beats-updated-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Accenture reports Q2 beats, updated guidance</a></h4><ul><li>        Accenture (NYSE:<a href='https://seekingalpha.com/symbol/ACN' title='Accenture plc'>ACN</a>) reports Q2 results that beat EPS and revenue estimates with a 15.3% Y/Y revenue growth.</li><li>               Updated FY18 guidance has revenue up 7% to 9% from $37.3B to $38B (consensus: $38.39B; was: +6% to 8%) and EPS from $6.61 to $6.70 (consensus: $6.68; was: $6.48 to $6.66).&nbsp; Operating margin expected at 14.8% (was: +10 to 30 bps), operating cash flow from $5.2B to $5.5B (was: $5B to $5.3B), and FCF from $4.6B to $4.9B (was: $4.4B to $4.7B).&nbsp;</li><li>               Revenue breakdown: Communications, Media &amp; Technology, $1.93B (+15% in USD); Financial Services, $2.02B (+14%); Health &amp; Public Service, $1.64B (+9%); Products, $2.63B (+16%); Resources, $1.34B (+17%).&nbsp;</li><li>               Key metrics: New bookings, $10.3B; Consulting bookings, $5.7B; Outsourcing bookings, $4.6B; gross margin, 29.7%; SG&amp;A expenses, $1.57B; effective tax rate (including U.S. tax law changes), 26.1%; operating cash flow, $924M; FCF, $791M; Days services outstanding, 40 days; total cash balance, $3.6B.&nbsp;</li><li>               Earnings call is scheduled for 8 AM ET with a webcast available <a href=\"https://investor.accenture.com/\" target=\"_blank\">here</a>.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17109206-accenture-reports-strong-second-quarter-fiscal-2018-results\" target=\"_blank\">Press release</a>&nbsp;</li><li>               Accenture shares are&nbsp;<font color='red'>down 0.4%</font>&nbsp;premarket. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3340913-accenture-beats-0_09-beats-revenue\" target=\"_blank\">Accenture beats by $0.09, beats on revenue</a> (March 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340928\" data-linked=\"Accenture reports Q2 beats, updated guidance\" data-tweet=\"$ACN - Accenture reports Q2 beats, updated guidance https://seekingalpha.com/news/3340928-accenture-reports-q2-beats-updated-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3340928-accenture-reports-q2-beats-updated-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340916\" data-ts=\"1521716323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNGX\" target=\"_blank\">SNGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340916-soligenixs-rivax-orphan-drug-in-europe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Soligenix&#39;s RiVax an Orphan Drug in Europe</a></h4><ul><li>The European Commission grants <a href=\"https://seekingalpha.com/pr/17109172-soligenix-receives-orphan-drug-designation-european-commission-rivax-prevention-ricin\" target=\"_blank\">Orphan Drug status</a> for Soligenix's (NASDAQ:<a href='https://seekingalpha.com/symbol/SNGX' title='Soligenix, Inc.'>SNGX</a>) ricin toxin vaccine RiVax. Among the benefits of the designation there is a 10-year period of market exclusivity for the indication, if approved.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3274694-soligenix-nabs-2m-new-government-funding-ricin-toxin-vaccine\" target=\"_blank\">Soligenix nabs $2M in new government funding for ricin toxin vaccine</a> (June 21, 2017)</li><li><strong>Update</strong>: Shares are up&nbsp;<font color='green'>12%</font>&nbsp;premarket on modest volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340916\" data-linked=\"Soligenix&#39;s RiVax an Orphan Drug in Europe\" data-tweet=\"$SNGX - Soligenix&#39;s RiVax an Orphan Drug in Europe https://seekingalpha.com/news/3340916-soligenixs-rivax-orphan-drug-in-europe?source=tweet\" data-url=\"https://seekingalpha.com/news/3340916-soligenixs-rivax-orphan-drug-in-europe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340914\" data-ts=\"1521715931\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTNP\" target=\"_blank\">TTNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340914-titan-pharma-out-licenses-rights-to-probuphine-to-l-molteni\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Titan Pharma out-licenses rights to probuphine to L. Molteni</a></h4><ul><li>Titan Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TTNP' title='Titan Pharmaceuticals, Inc.'>TTNP</a>) inks an <a href=\"https://seekingalpha.com/pr/17108950-titan-executes-agreement-acquisition-molteni-probuphine-europe-select-territories\" target=\"_blank\">agreement </a>with Italian pharma L. Molteni &amp; C. dei F.lli Alitti Societ&agrave; di Esercizio S.p.A. granting it commercialization rights to Probuphine in Europe, certain countries in the Commonwealth of Independent States, the Middle East and North Africa. The contract supersedes the term sheet executed in November 2017.</li><li>Under the terms of the deal, Titan will receive &euro;2.0M upfront, up to &euro;4.5M in milestones and low-teens-to-mid-twenties earn-out payments for up to 15 years.</li><li>Molteni has also purchased $2.4M of Titan's $4.0M outstanding balance of a loan from Horizon Technology Finance Corp. Under certain conditions, Molteni may convert the amount into Titan common stock at $1.20 per share. In connection with this transaction, Titan has issued warrants to Molteni and Horizon for the purchase of up to 580K common shares at $1.20 per share.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3314822-titan-pharma-engage-molteni-distribute-probuphine-europe-shares-ahead-2-percent\" target=\"_blank\">Titan Pharma to engage Molteni to distribute Probuphine in Europe; shares ahead 2%</a> (Nov. 28, 2017)</li><li><strong>Update</strong>: Shares are up<font color='green'> 20%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340914\" data-linked=\"Titan Pharma out-licenses rights to probuphine to L. Molteni\" data-tweet=\"$TTNP - Titan Pharma out-licenses rights to probuphine to L. Molteni https://seekingalpha.com/news/3340914-titan-pharma-out-licenses-rights-to-probuphine-to-l-molteni?source=tweet\" data-url=\"https://seekingalpha.com/news/3340914-titan-pharma-out-licenses-rights-to-probuphine-to-l-molteni\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":70,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}